Content uploaded by Adriana Farah
Author content
All content in this area was uploaded by Adriana Farah on Jan 30, 2018
Content may be subject to copyright.
Achieving sustainable
cultivation of coffee
Breeding and quality traits
Edited by Dr Philippe Lashermes
Institut de Recherche pour le Développement (IRD), France
BURLEIGH DODDS SERIES IN AGRICULTURAL SCIENCE
E-CHAPTER FROM THIS BOOK
http://dx.doi.org/10.19103/AS.2017.0022.14
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Chapter taken from: Lashermes, P. (ed.), Achieving sustainable cultivation of coffee, Burleigh Dodds Science Publishing,
Cambridge, UK, 2018 (ISBN: 978 1 78676 152 1; www.bdspublishing.com)
Nutritional and health effects of coffee
Adriana Farah, Federal University of Rio de Janeiro, Brazil
1 Introduction
2 Nutrients and bioactive compounds of coffee
3 Main beneficial health effects of coffee
4 Potential side effects of coffee drinking
5 Final considerations
6 Acknowledgements
7 Where to look for further information
8 References
1 Introduction
Good health and well-being are essential for all humans and depend upon good nutrition.
Only when an individual has good health can he or she fully utilize their physical and
mental potentials.
Since the beginning of humanity, plant foods have been used to promote health and
prevent disease. Coffee has been exalted by people of different nations and times not
only because of its distinctive aroma and taste but also due to its stimulating and health-
promoting effects (Bizzo et al., 2015).
The earliest potential references to coffee consumption are found in the Old Testament,
where a bean was referred to as a ‘parched pulse’, and the first written mention of coffee is
attributed to Razes, a tenth-century Arabian physician, who indicated that coffee cultivation
may have begun as early as 575 AD (Smith, 1987; Folmer et al., 2017). However, the first
written documentation of the medicinal properties and uses of coffee was reported by
the Middle Eastern physician, Avicenna (980–1037 AD), who used it as a decongestant,
muscle relaxant and diuretic infusion. It is said that in the thirteenth century, a doctor-priest
from Mocha, Sheikh Omar, also discovered coffee in Arabia and used it as a cure for many
different types of illnesses (Ukers, 1935). The earliest coffee houses opened in Mecca
in the fifteenth century, but were primarily reserved for religious purposes. After they
were popularized, following a trip to Aleppo, Dr. Leonard Rauwolf, a German physician,
introduced the beverage to Western Europe in the sixteenth century and referred to it as
being ‘almost as black as ink and very good in illness, chiefly that of the stomach’ (Ukers,
1935; Folmer et al., 2017).
Nutritional and health effects of coffee
2
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Neither the Greek physician Hippocrates (460–377AD) nor the Roman physician Aelius
Galenus (129–199 AD), who later expanded Galenic theories, ever mentioned coffee, as
it was not consumed in their region at that time. However, the followers of Hippocratic–
Galenic medicine, which dominated physiology from the fourth century BC to the
nineteenth century, used it to balance the body’s ‘humours’ in accordance with individual
temperaments. Coffee was considered to be beneficial to people with a lymphatic or
bilious temperament, whereas sanguine or nervous subjects were advised to use it more
reservedly. Consequently, coffee houses, which were first introduced in Europe in the
seventeenth century, were often recommended for those suffering from maladies as part
of their treatment (Bizzo et al., 2015). In the eighteenth century, they also became places
for social gathering and commerce, and over time, more coffee houses opened up and
became popular (Folmer et al., 2017).
Despite its recognition as a medicinal agent or simply a beverage with an attractive taste,
throughout history, coffee has occasionally been seen as a villain, and to date, remainders of
this reputation still exist. The perception of coffee as an intoxicating drug and the sensitivity
of some people to caffeine are the main reasons for this, along with past discussions on
its potential contribution to the development of cancer or other diseases. However, over
the last few decades, the appearance of modern scientific technology, in combination
with large and reliable databases and sophisticated statistics, has enabled the separation
of confounding factors in epidemiological studies such as existing medical conditions,
smoking or a poor-quality diet. Additionally, an increasing number of studies have proved
that despite its nutritional limitations, coffee is a complex mixture of bioactive substances
that may act together to help prevent diseases when consumed appropriately. In view of
this, our understanding of coffee and its healthful properties has changed dramatically.
Currently, the general opinion is that moderate coffee consumption is not associated with
increased long-term risks amongst healthy individuals and can be incorporated into a
healthy and diverse diet, in combination with other healthful behaviours (US Department
of Agriculture – USDA, 2015).
This chapter presents a brief literature review of the nutritional and main health-related
aspects of regular coffee consumption.
2 Nutrients and bioactive compounds of coffee
The chemical composition of roasted coffee beans has been detailed in previous
chapters. In summary, they contain approximately 43% carbohydrates (of which 70–85% is
comprised of polysaccharides, arabinogalactans, mannans and glucan, and the remaining
amount includes sucrose, reducing sugars, lignins and pectins); 7.5–10% proteins; other
nitrogenous compounds (1% caffeine, 0.7–1% trigonelline and 0.01–0.04% nicotinic acid);
10–15% lipids (of which approximately 75% correspond to triacylglycerols, 18.5% to esters
of diterpens and free diterpens and the remaining amount to esters of sterols, free sterols,
sterylglucosides, waxes, tocopherols and phosphatides); 25% melanoidins, 3.7–5%
minerals and ~6% organic and inorganic acids, and esters (1–4% chlorogenic acids and
other phenolic compounds, 1.4–2.5% aliphatic acids and quinic acid and <0.3% inorganic
acids), in addition to other minor compounds that may be exclusive to a particular species
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 3
(Farah, 2012; Speer and Kölling-Speer, 2017). In this chapter, we will focus on the most
common species found around the world, Coffea arabica and Coffea canephora, which
are also the most consumed and the only species studied with respect to human health.
The coffee beverage or brew is an aqueous extract derived from the infusion or
percolation of roasted and ground coffee beans, using hot or cold water. The reported
amounts of nutrients, main bioactive compounds and other non-nutrients in coffee
brews are presented in Table 1. It is worth noting that a coffee brew exhibits very high
variability in terms of chemical composition due to many possible variations in raw
material production, processing and brewing, which lead to the final product (the brew).
The first variable is the blend, which can contain different percentages of coffee beans,
each with distinct chemical compositions derived from genetic aspects, origin and degree
of maturation (the latter being considered only in the case of a lower quality blend), grown
under different conditions and processed via varying postharvest methods. There are
also many existing types of roasting profiles and roasting degrees. The roasted beans
can then be ground to different sizes and the proportion of powder to water classically
used can change dramatically between countries and cultures. For example, whilst in
most European countries, the use of 6 g per 100 mL is common for filtered coffees, in
Brazil, 10 g or more is used. In Italy, 20 g of ground roasted coffee is also not uncommon
for 100 mL. In espresso coffee, although traditionally 6–8 g is used per 25 mL water,
an extreme proportion of 10 g per 25 mL water is nowadays often used by third-wave
baristas. In addition, there are a variety of brewing methods where pressure, temperature
and contact time between the water and the ground coffee vary, and therefore require
different amounts of powder. Some methods use filters made up of different materials,
which may also influence the composition of the final brew. On top of all this, the size of
a cup can vary from about 25 mL for an Italian espresso to 600 mL (20 oz) in the United
States. The standard American cup, however, is often reported as being equivalent to
approximately 250 mL (8 fluid oz). The traditional European filter cup has been defined
in different studies, including that of Floegel et al. (2012), as containing 150 mL. Finally,
analytical methods may cause differences in the reported compositional results, especially
for the least sensitive and specific methods. Thus, it is understandable that there are no
rigorous standard values that represent the chemical composition of a cup of coffee, but
rather a range of values. Table 1, therefore, reports the ranges of values found in the
literature, but higher or lower values can be found, depending on the compound.
It is worth noting that the yield of a brew (i.e. the amount of solids extracted from the
ground coffee found in a cup) may vary from as low as 14% to as much as 60% during
soluble coffee production, thus affecting the composition of the brew. Further to this, the
extractability of a compound by water will also depend on the amount of soluble solids
in the water. Water, containing a high amount of minerals like calcium, magnesium and
chloride may extract less solids from the ground coffee, and may also influence the flow
time in an espresso machine (Folmer, pers. comm.). Considering that up to 40 g of coffee
could be used to prepare 100 mL of a coffee beverage, the amount of soluble solids in
coffee brews has been reported to vary from 2 to 6 g per 100 mL cup (Pettraco, 2005) (also
referred to as a TC ranging from 2 to 6%). In the traditionally weaker American coffees,
measurements of the amount of solids in a few cups yielded 1.2–1.5 g per 100 g. It is worth
highlighting that the amount of solids depends upon the degree of roasting.
The main components of the brew are now briefly described.
Nutritional and health effects of coffee
4
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Table 1 Content range of nutrients, bioactive compounds and other non-nutrients in coffee brews
obtained from ground and roasted blends of C. arabica species or blends of C. arabica and C. canephora
species (Trugo, 1985; Macrae, 1985; Clifford, 1985; Urgent et al., 1995; Nunes et al., 1997; Balzer, 2001;
Alcázar et al., 2003; Petracco, 2005; Boekschoten et al., 2006; Lang et al., 2010,2011; Farah, 2012; Rubach
et al., 2014; Lachenmeier, 2015; USDA, 2017; Glória and Engeseth, 2017)
Nutrients and non-nutrients
Content rangea
(from blends of C. arabica or C. arabica and C. canephora sp.)
Macronutrients mg per 100 mL
Water 94 000–98 500 (TC 1.5–6%)
Simple sugarsb0–100 (one report up to 200 mg)
Proteins 120–400
Lipids 180–400
Soluble fibresc200–700 (more commonly between 400 and 500)
Aliphatic acids and quinic acidf692–2140
Vitamins:
Thiamin (B1) 0.001
Riboflavin (B2) 0.177
Niacin (B3, nicotinic acid)d0.8–10 (more commonly up to 5)
Pyridoxine (B6) 0.002
Folate (B9, DFE)e1
Vitamin C, total ascorbic acid 0.2
Vitamin E (alpha-tocopherol) 0.01
Vitamin K (phylloquinone) 0.1
Tocopherols (α, β, γ) Traces, only in unfiltered coffees
Minerals: Total ashes 150–500
Potassium, K 115–320
Calcium, Ca 2–4
Sodium, Na 1–14
Phosphorus, P 3–7
Iron, Fe 0.02–0.13
Zinc, Zn 0.01–0.05
Manganese, Mn 0.02–0.05
Bioactive compounds mg per 100 mL
Caffeine 50–380 (commonly between 50 and 150)
Trigonelline 12–50
N-methylpyridinium 2.9–8.7
Diterpenes (cafestol and kahweol) 0.2–1.5 (paper filtered); 2.6–10 (boiled)
Chlorogenic acids 32–500 (commonly 50–150)
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 5
2.1 Macronutrients
As with other types of plant beverages, coffee brews do not contain excessive amounts of
macronutrients (absorbable carbohydrates, proteins and lipids) and calories, unless they are
consumed with sugar, milk or cream. According to the USDA National Nutrient Database
(2017), 100 mL of filtered coffee (breakfast blend) contains approximately 2 kcal. Exceptions
include boiled coffees and similar types of brews, which contain a reasonable amount of
lipids as both soluble and insoluble materials are consumed. The nutritional quality of coffee
proteins is limited and approximately 50% of this fraction is insoluble and lacks the essential
amino acid, tryptophan (Macrae, 1985). In addition, during roasting, most simple sugars and
proteins are degraded or changed via the Maillard and pyrolysis reactions and so the amount
of protein in the cup is low (120–400 mg per 100 mL, USDA 2017). The detection of up to
200 mg per 100 mL of simple sugars, mainly arabinose, galactose and mannose, and lower
amounts of sucrose, fructose and glucose, has been reported for brewed coffee and dissolved
soluble coffee at 2% (coffee/water), with the latter being higher (Macrae, 1985; Trugo, 1985).
Galactomannans and type 2 arabinogalactans are considered to be the predominant soluble
dietary fibres in a coffee beverage (often between 140 and 650 mg per 100 mL), of which
approximately 70% is comprised of galactomannans (Gniechwitz et al., 2007; Farah, 2012);
however, care is needed to distinguish polysaccharides from total carbohydrates in order to
avoid overestimation.
Nutrients and non-nutrients
Content rangea
(from blends of C. arabica or C. arabica and C. canephora sp.)
Sum of other phenolic
compounds
0.1–0.2
Melanoidins 500–1500
β-carbolins (norharman and
harman)
0.004–0.08
Serotonin 0–1.4
Melatonin 0.006–0.008
Polyamines (spermine and
spermidine)
0.4
Some undesirable compoundsgµg per 100 mL
Acrylamide 3.9–7.7
5-hydroxytryptamidesh1.2–34.3 (filtered), 350–840 (espresso and French press)
Furani3.8–262
a Content varies with blend, origin, agricultural practices, roasting method and degree, grid, brewing method,
amount of coffee powder to water and analytical method.
b Arabinose, mannose, galactose, sucrose and minor monosaccharides.
c Polysaccharides, mainly galactomannans and type II arabinogalactans.
d Daily recommendations for adults:16 mg for men and 14 mg for women (WHO/FAO, 2002).
e Dietary Folate Equivalent.
f pH 4.3 (acidic coffee, light roast), to 5.8. Common values around 5.0.
g These undesirable compounds do not include incidental contaminants.
h N-alkanoyl-5-hydroxytryptamides (C5HTs).
i Content decreases rapidly after brew preparation.
Nutritional and health effects of coffee
6
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
2.2 Micronutrients
With regards to micronutrients, the brew may contain a reasonable amount of vitamins and
minerals. Niacin, in the form of nicotinic acid, is the main vitamin in a coffee brew and is
also known as vitamin B3 or PP (pellagra preventing), and participates as a coenzyme in
various metabolic processes involved in energy metabolism and tissue health. Additionally,
it contributes to the normal functioning of the nervous system, among many other functions.
Deficiency of this vitamin causes pellagra, a disease characterized by skin lesions and
diarrhea, among other symptoms (Arauz et al., 2015). Regular coffee consumption can supply
an essential part of the daily recommendation for adults, which is 16 mg for men and 14 mg
for women according to FAO standards (WHO/FAO, 2002). Niacin can also be produced
in the liver from a reasonable amount of tryptophan (60mg thyptophan makes 1mg niacin),
which is present in animal proteins, nuts, and some other seeds. The intake of niacin from
coffee is particularly important in places where tryptophan consumption is low, such as in the
rural and less developed areas of Central America and Central Africa where corn (which is
poor in niacin and tryptophan) is the staple food (Carpenter, 1983; Macrae, 1985). However,
it is worth noting that people who consume corn as tortillas or similar foods made with corn
flour pre-treated with alkaline water are not at risk of niacin deficiency as those who consume
untreated corn and corn flour (Carpenter, 1983). Most recently, supplementation of nicotinic
acid has been used to decrease low and very low density lipoproteins (LDL and VLDL) levels
(Le Bloch et al., 2010) and to contribute to the hepatoprotective effect of coffee (Arauz et al.,
2015) and therefore, an additional food source of niacin, like coffee is welcome considering
that excess amounts of the vitamin are excreted in urine (Wang et al, 2001).
Coffee brews may also contain very small amounts of nicotinamide, another form of niacin,
and other B vitamins (thiamin, riboflavin, pyridoxine, folic acid), ascorbic acid (vitamin C), and
phylloquinone (vitamin K) (Macrae, 1985; USDA 2017). Unfiltered coffees can contain small
residual amounts of tocophenols (α, β and γ – the latter two predominate), although during
and after roasting almost all of the original amount in green coffee (about 60 mg/100g) is
degraded or oxidized (Macrae, 1985).
Considering the different factors that create a large variability in the composition of
roasted coffee, in addition to differing brewing methods and the extractability of different
minerals, the values of total ash ranging between 150 and 500 mg per 100 mL have been
reported, including data from dissolved soluble coffee (containing 7–10% ash), prepared
at 2% (ground coffee to water). For infusions prepared from ground coffee in Poland
(Grembecka et al., 2007), the consumption of 300 mL (2 cups) was estimated to supply,
on average, 4.5% of the recommended dietary allowance (RDA) for Mg, 3.5% for K, 2.8%
for Mn, 2.4% for Cr, 1.9% for P, 0.32–0.43% for Ca and Na, 0.26–0.33% for Cu and Fe,
0.13% for Zn and 2.6–15.6% for Ni. Higher average percentages were estimated from the
ingestion of a 300-mL beverage prepared from instant coffee: 12.3% for Mg, 8.9% for K,
8.6% for Mn, 4.9% for Cr, 7.4% for P, 1.6% for Ca, 2.5% for Na, 0.32% for Cu, 2.9% for Fe,
0.35% for Zn and 4.9–29.7% for Ni. Estimates indicate that the consumption of coffee in
typical amounts does not exceed the tolerance limits for the ingestion of toxic metals, such
as Pb and Cd.
In a study performed in Portugal (Oliveira et al., 2012), two cups of instant coffee (total of
4 g) were estimated to supply 9.5% of the RDA for K, 5.2% for Mg, 4.4% for Mn, 3.5% for
Ni, 2.2% for P, 1.5% for Fe, 0.5% for Cr, 0.4% for Ca and 0.2% for Na. In a more recent study,
also performed in Portugal (Oliveira et al., 2015), one cup of an espresso coffee beverage
(prepared from 5 to 6 g of ground coffee) was estimated to provide 5.2–7.0% of the RDA for
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 7
K, 2.8–7.2% for P, 1.4–2.2% for Mg, 1.4–1.9% for Mn, 0.14–0.28% for Ca, 0.07–0.15% for Fe
and <0.02% for Na.
Other similar studies indicate that regular coffee intake (300 mL) does not contribute,
in most cases, to amounts higher than 10% of the daily recommendations in different
countries.
2.3 Bioactive compounds
It is well known that nutrients are required to maintain normal body functions and are
therefore bioactive. However, the term ‘bioactive compounds’ commonly refers to minor
food constituents that exert biological functions other than nutritional functions. These
compounds are commonly found in plants, and in a few animals that feed on them, and
their chemical structures and biological functions vary widely.
Although most health-related aspects of coffee have been attributed to the beverage
and not to individual compounds, mechanistic studies have suggested that some specific
bioactive compounds play key roles as co-adjuvant agents in disease prevention. In
addition to caffeine, the most studied bioactive compounds of coffee are chlorogenic acids
and their lactones, trigonelline and their derivatives, the diterpenes, cafestol and kahweol
and melanoidins. The polysaccharides, galactomannans and type II arabinogalactans,
and β-carbolines are amongst the emerging bioactive compounds for which there is still
insufficient information to substantiate any health effects. Also, relatively recently, it has
been suggested that some coffee amines exert positive effects on health when consumed
in low quantities, which are referred to as bioactive amines. Each of these compounds or
group of compounds will be introduced hereafter and their effect on health will be briefly
discussed. The main undesirable compounds in coffee are also introduced.
2.3.1 Caffeine
Caffeine is the most well-studied compound present in coffee, and its mechanisms of
function are generally well documented. First, there are psychostimulating effects which
include an acute impact on mental performance as well as long-term influence on the risk
of developing neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Caffeine
has also been found to improve physical performance, which will be discussed in the next
section on the health effects of coffee. Most recently, a number of studies have reported
new bioactive effects for caffeine, and one of the emerging effects is the enhancement
of the antioxidant effect of coffee. Caffeine metabolites, especially 1-methylxantine and
1-methylurate, have exhibited an antioxidant activity in vitro (Moura-Nunes et al., 2009).
Corroborating these results, the average plasma iron-reducing capacity of human subjects
after regular coffee consumption was higher than that recorded after the consumption of
decaffeinated coffee, suggesting that whole coffee is more efficient than decaffeinated
coffee with respect to its antioxidant capacity (Moura-Nunes et al., 2009).
There are a few in vitro studies showing that caffeine contributes to the antibacterial effect
of coffee against Streptococcus mutans, a significant contributor to cariogenic bacteria, as
well as intestinal pathogenic bacteria (Antonio et al., 2010). Over the last few years, it has
also been suggested that caffeine exerts an antihyperlipidemic effect (decreased storage
of triglycerides and cholesterol) by inhibiting lipogenesis and stimulating lipolysis through
the regulation of the gene expression responsible for lipid metabolism in liver cells (Quan,
2013). These are just a few of the various emerging effects of caffeine.
Nutritional and health effects of coffee
8
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
2.3.2 Chlorogenic acids and their derivatives
Chlorogenic acids and their derivatives – Chlorogenic acids are the main phenolic compounds
in coffee and this group of compounds includes approximately ten major esters and four
major lactones (produced during roasting), in addition to dozens of trace compounds. The
total amount of chlorogenic acids in C. canephora beans is almost double than that found
in C. arabica beans, and because chlorogenic acids are partly degraded or transformed
during roasting, dark roasted coffees contain lower amounts of these compounds. In roasted
products, the difference between species is significantly reduced.
These compounds are frequently referred to as powerful antioxidants and anti-
inflammatory compounds due to the results of in vitro and animal studies, as well as a
few human studies (Santos et al., 2006; Torres and Farah; 2016, Folmer et al., 2017), but
the mechanism of action of the different compounds and how they are related to the
prevention of the disease remains, to a large extent, unknown.
Owing to the high concentration of chlorogenic acids in coffee brews (Table 1),
compared with chlorogenic acids and other phenolic compounds in foods, in general, they
may play a major role in the diet of consumers as a source of antioxidative compounds.
The significant contribution of chlorogenic acids to the dietary intake of antioxidative
compounds is exemplified in a number of reports from different countries in which, based
on their official food consumption database or other types of surveys, coffee was the main
contributor to total dietary antioxidant capacity, that is, Brazil (66%), Norway (64%), Italy
(38% for women and 27% for men), Spain (45%), Japan (56%) and the Czech Republic
(54.6% for women and 43.1% for men) (Torres and Farah, 2016). However, it should be
kept in mind that the intake of chlorogenic acids from coffee does not replace the intake
of antioxidants from other foods, as each has its own specific bioactivity.
Together with other polyphenols, carotenoids and additional classes of antioxidative
compounds, chlorogenic acids and their lactones have been associated with a decrease in
the risk of Alzheimer’s and type 2 diabetes, amongst various degenerative diseases (Kasai
et al., 2000; Obuleso et al., 2011; Farah, 2012).
Long before epidemiological studies investigated the association between coffee
consumption and health effects, the antimutagenic property of chlorogenic acids and their
metabolites was discovered. Recent studies have confirmed these findings and elucidated
several mechanisms of chemopreventive action, which include modulating the expression
of the enzymes that are involved in endogenous antioxidant defences, DNA replication,
cell differentiation and ageing (Feng et al., 2005; Ramos, 2008;Jurkowska, 2011), metal
chelation, inactivation of reactive compounds and metabolic pathway changes (Kasai et
al., 2000; Farah, 2012). In the colon, for example, chlorogenic acids may inactivate free
reactive radicals and as a result help prevent colon cancer (Ludwig et al., 2014).
Additional health effects observed in vitro and in animal studies include hepatoprotective
(including cirrhosis, liver cancer and other liver diseases), immune-stimulatory and
antibacterial and antiviral activities. Synthetic derivatives of these compounds have also
inhibited HIV-1 replication in cells, which could play a role in research towards drugs
that inhibit HIV (Farah, 2012). Additionally, recent in vitro studies have suggested that
after coffee consumption, the unabsorbed portion of chlorogenic acids may serve as a
substrate to stimulate the growth of beneficial intestinal bacteria; however, this effect
requires further investigation due to conflicting data in different studies (Sales et al., 2017).
Trace amounts of other phenolic compounds, that is, isoflavones, proantocyanidins
and lignans, have been identified in coffee (Farah and Donangelo, 2006), which possibly
enhance the beneficial effects of chlorogenic acids.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 9
2.3.3 Melanoidins and polysaccharides
Melanoidins and polysaccharides – Coffee melanoidins have gained importance over the
years because of their contribution to, amongst others, the antioxidant and antimicrobial
effects of coffee (Rufián-Henares and Morales, 2007). This is at least, in part, due to the
incorporation of chlorogenic acids and other bioactive compounds into their structure
during roasting (Farah, 2012).
As melanoidins are not digested, they may act, in combination with coffee polysaccharides
(mainly galactomannans and type II arabinogalactans), as soluble dietary fibres. They are
largely indigestible and thus fermented in the gut (Borrelli et al., 2004; Gniechwitz, 2008).
A recent study concluded that the consumption of 0.5–2 g melanoidins per day (present
in 2–5 cups) contributes up to 20% of the recommended 10 g of daily soluble dietary fibre
intake. It has also been hypothesized that these substances may stimulate the growth of
beneficial bacteria in the lower digestive tract (Fogliano and Morales, 2011), in the same
way as chlorogenic acids; however, the data remain controversial.
As with chlorogenic acids (Passos et al., 2014), it has been hypothesized that melanoidins
can enhance immune-stimulating properties and contribute significantly to reducing the risk
of colon cancer (Vitaglione et al., 2012; Moreira et al., 2015; Fogliano and Morales, 2011),
which might occur in different ways: i) by increasing the elimination rate of carcinogens
through higher colon motility and faecal output, ii) by decreasing colon inflammation
through improved microbiota balance (prebiotic effect) and iii) by serving as a ‘sponge’ for
free radicals in the gut (Garsetti et al., 2000; Folmer et al., 2017).
2.3.4 Trigonelline and derivatives
Trigonelline and derivatives – Trigonelline is another compound that has gained importance
in recent years due to its potential contribution to the protective effect of coffee against
diseases. In vitro and animal studies have reported different involvements of trigonelline
against type 2 diabetes (Yoshinari and Igarashi, 2010), as well as neuroprotective (Hong et al.,
2008; Tohda et al., 2005), antitumour (Hirakawa et al., 2005) and phytoestrogenic effects
(Farah, 2012). Beans from C. arabica species contain higher amounts of this compound,
compared with C. canephora, and as with chlorogenic acids, trigonelline undergoes changes
and degradation during roasting; hence, dark roasted coffees contain low amounts. However,
10–20% of the original amount of trigonelline is converted into nicotinic acid (niacin) (Farah,
2012). In addition to its vitamin function, niacin is also involved in other bioactive functions,
presenting antidiabetic (Yoshinari and Igarashi, 2010), antioxidant and hepatoprotective (Arauz
et al., 2015) effects in vitro and in animal studies. The compound n-methylpyridinium and
other pyridinium derivatives are additional thermal degradation products generated by the
decarboxylation of trigonelline. It has been reported that like trigonelline, n-methylpyridinium
promoted higher glucose utilization in liver cells, stimulating cellular energy metabolism and
contributing to the protective effect against type 2 diabetes (Riedel et al., 2014). Pyridinium
derivatives have also been reported to present antioxidant/chemopreventive (Somoza et
al., 2003), hepatoprotective (Gebicki et al., 2008), vasoprotective (Lang et al., 2011) and
antithrombotic effects (Kalaska et al., 2014).
2.3.5 Diterpenes
Diterpenes – Cafestol and kahweol are diterpenes present in coffee mainly in the form of
salts or esters of (predominantly) saturated and unsaturated fatty acids. They represent
Nutritional and health effects of coffee
10
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
approximately 20% of the lipid fraction of coffee, with cafestol being more abundant. Higher
levels of diterpenes are found in C. arabica than in C. canephora species. Coffee diterpenes
exhibit strong anticarcinogenic and hepatoprotective properties in vitro (Farah, 2012).
Diterpene levels in the coffee cup vary significantly based on the natural variations in
green coffee beans, roasting conditions and preparation methods (Urgert et al., 1997; Gross,
1997;Urgert and Katan, 1995). Whilst filtered and soluble coffees are practically diterpene-
free (due to their poor solubility in water, they are trapped by paper filters), espresso-based
methods contain higher levels of diterpenes, which are, on the other hand, significantly
lower than those found in French press or Turkish coffee (2–10 mg per cup) (Farah, 2012).
2.3.6 β-carbolines
β-carbolines – These are alkaloids formed in coffee mainly during roasting and the
two identified β-carbolines in coffee are norharman and harman. Despite some past
controversies regarding the neurological and toxicological effects of these compounds
in studies using high doses in animals, β-carbolines have been recently associated
with potentially positive effects, including neurological ones, with antidepressive and
neuroprotective properties. It has also been suggested that they may reduce the risk of
diabetes. The total concentration of these compounds in the brew is highly variable in the
literature, from 4 to 80 µg per 100 mL, but typical concentrations are reported to be in the
range of 4–20 µg per 100 mL, being primarily dependent on the coffee species. Roasted
C. canephora beans have consistently higher amounts of β-carbolines than C. arabica
beans (Farah, 2012;Rodrigues and Casal, 2017;Casal, 2017).
2.3.7 Bioactive amines
Bioactive amines – These compounds are organic bases with psychoactive, neuroactive or
vasoactive activity and participate in a number of processes in the human body. Coffee amines
that present positive health effects in in vitro and in animal studies, other than their known
physiological effects in the body, are called bioactive amines. However, no direct association
between their presence in coffee and benefits to human health has been found. The main
bioactive amines are the indolamines, serotonine and melatonin, and the polyamines,
spermine and spermidine. Mean reported concentrations of serotonin in coffee beverages
vary from non-detected to 90 µg per 100 mL in most coffee beverages, but from 372 to
1354 µg per 100 mL in Turkish coffee. Information regarding melatonin is rare; however,
levels ranging from 6 to about 8 µg per 100 mL have been found. Although serotonin is
a neuroactive substance with various positive effects on well-being, serotonin from the
diet cannot cross the blood–brain barrier and can only be produced in the brain; however,
serotonin from the diet can have other potentially relevant roles including broncho- and
vasoconstrictor, antihypertonic, antioxidant and antiallergic and antidiuretic effects. It can also
help to modulate the volume and acidity of gastric juice. Spermine and spermidine (reported
amounts for each vary from non-identified to more than 150 µg per 100 mL brew) are efficient
free radical scavengers in several chemical and enzymatic systems. Other amines have also
shown positive effects on health when in low quantities (Gloria and Engeseth, 2017).
2.4 Undesirable compounds in coffee
A few compounds derived from microbial contamination (ocratoxin A, biogenic amines),
pesticides or chemical reactions that occur during the roasting process (mainly acrylamide,
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 11
furan and polycyclic aromatic hydrocarbons – PAH) have been of concern to health authorities
such as the Food and Drug Administration (FDA), Food and Agriculture Organization of the
United Nations (FAO) and the European Food Safety Authority (EFSA).
2.4.1 Ocratoxin A
Ocratoxin A and similar toxins are derived from green bean contamination with mould and
can be avoided by carefully harvesting, processing and storing coffee, which is reflected in
good quality. Ocratoxin A is gradually degraded by the high temperatures of roasting and
its residual levels in roasted coffee are regulated in many countries. In the European Union,
regulation 1881/2006 states that for roasted coffees, the maximum limit is 5 µg per kg.
2.4.2 Pesticides
Pesticides comprise a large number of substances belonging to different chemical groups,
which are used to control plant diseases, pests or weeds. They can be neurotoxic or inhibit
vital metabolic reactions in living beings, targeting different mechanisms, and individual
pesticides present different levels of toxicity. In order to protect human safety and health
resulting from pesticide application during coffee production, many countries have put these
chemicals under strict legislation and surveillance. For example, in the United States, the FDA
establishes the maximum amount of a pesticide allowed to remain in food, as part of the
process of regulating pesticides. Presently, tolerance limits for about 43 pesticides in coffee
are listed by the FDA. In Japan, the maximum tolerated residual limits are amongst the lowest
(often 0.01 ppm). Despite all the regulations, pesticide residues have been found via analyses
of green coffee performed prior to importing at differing occasions and in different countries.
Due to restrictions and monitoring, the residual levels of pesticides in commercial ground
and roasted coffees are usually very low and within the established limits. The solubility
of residual pesticides after roasting is often low and therefore low amounts are found in
the brew, especially in filtered coffee. However, the toxicity of their metabolites in seeds or
degradation products during roasting has not been well studied and could be higher than
that of the pesticides themselves (Farah, 2012; Cunha and Fernandes, 2017).
2.4.3 Acrylamide, furan and PAH
Acrylamide, furan and PAH are derived from reactions that occur during roasting, more
specifically Maillard and pyrolysis (Farah, 2012), which can occur in many other heated
foods such as French fries or bread. Studies assessing the risk of their concentrations in
brews have not found considerable amounts which could cause harm to human health, as
epidemiological studies have failed to find a link between these compounds in coffee and an
elevated risk of cancer or other diseases (Lipworth et al., 2012; Nkondjock, 2012).Amongst all
these compounds, acrylamide is the most abundant and the one which many food and health
authorities have been most concerned about. It is formed at the beginning of the roasting
process and its levels decrease thereafter to a certain degree (Farah, 2012). Acrylamide has
been associated with cancer in one study using laboratory rodents which were exposed to
extremely high concentrations (1000–10 000 times physiological ranges) (Mucci and Adami,
2009). Whilst the US FDA (FDA, 2016) reported that coffee is a significant source of acrylamide
exposure for adults, the EFSA’s recent opinion on acrylamide stated that health authorities
do not see any direct evidence of cancer risk (EFSA 4104, 2015b; Folmer et al., 2017). The
Nutritional and health effects of coffee
12
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
European Commission’s recommended indicative value is 450 µg acrylamide per kg of roast
and ground coffee, a level which is generally achievable for commercial products.
Furan, hydroxymethylfurfural (HMF) and furfural are heterocyclic, low molecular weight
molecules with a furan ring and potential carcinogenicity in common. Furan has been
classified as a possible carcinogen (Group 2B) by the International Agency for Research
on Cancer (IARC). Group 2B status is assigned to compounds and exposure conditions
for which there is limited evidence of carcinogenicity in humans and insufficient evidence
of carcinogenicity in experimental animals, and therefore requires further investigation.
No human studies are available regarding the effects of furan and there is a significant
uncertainty in the extrapolation of risk from animal assays performed in the laboratory
to the equivalent risk for humans. When dealing with furfuryl and furan derivatives, the
EFSA report (EFSA, 2011) concluded that notwithstanding some indications of in vitro
genotoxicity, based on available data of exposure and on in vivo genotoxicity studies, which
gave negative results for the carcinogenicity evaluation in rats and mice, under normal
conditions, these compounds are of no concern to human health (Folmer et al., 2017).
Regulatory bodies, including the US FDA and the EFSA, have made no recommendations
regarding the maximum levels of furan in the dietary intake.
In coffee, these compounds are formed during the roasting stage mainly via thermal
degradation/Maillard reaction of reducing sugars, alone or in combination with amino
acids or via the thermal degradation of amino acids. The consumed levels of furan in coffee
are highly variable and reflect not only the preparation methods but also the roasting
conditions; however, these compounds are not exclusive to coffee. The major contributors
to furan exposure in adults and teenagers were estimated to be fruit juice, and milk-based
and cereal-based products. Additionally, jarred baby foods were also major contributors
in toddlers (Ferreira et al., 2017).
Examples of a range of furan concentrations, obtained using coffees from the Spanish
market prepared by different methods, are 12–146 µg per litre with the lowest values
found in instant and filtered coffee and the highest values found in espresso. Boiled
coffee was not evaluated. The concentration for commercially packed coffee capsules was
approximately 240 µg per litre. The furan content of coffee brews from automatic coffee
vending machines ranged from 11 to 262 µg per litre; however, this is not representative
of what people would consume. Due to its high volatility, after coffee preparation, losses
occur rapidly upon mixing and waiting for the brew to cool down (Ferreira et al., 2017).
The most important contributors of HMF in the diet are dried fruits, caramel, vinegar, bread
and coffee. The content of HMF in coffee samples from coffee vending machines (8 g of
ground coffee to 100 mL water) ranged between 4 and 60 mg per litre with a mean content
of 28.8 mg per litre. The concentrations of furfural in coffee brews from European vending
machines ranged between 0.30 and 1.30 mg per litre (Ferreira et al., 2017). To date, no
measures have been identified to mitigate furan without impacting the typical coffee aroma.
PAH, from which benzo[a]pyrene is the most relevant from a toxicity point of view,
can be formed in coffee and other foods that are severely roasted or exposed to very
high temperatures. This compound is classified by the IARC as probably carcinogenic
to humans. However, the level of exposure to PAH from coffee is low and within the safe
limits set by International Agencies (IARC, 2010; EFSA, 2008).
2.4.4 Biogenic amines
Biogenic amines are organic bases of low molecular weight that participate in the regular
metabolic processes of plants, microorganisms and animals. They are produced in the
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 13
body and can also be provided by the diet and from the microbial flora of the intestine; at
high concentrations, however, they can pose a toxicological risk.
Examples include histidine, tyramine, tryptamine, cadaverine and putrescine. Histidine
is the most toxic and is associated with a hypotensive effect and headaches. Putrescine,
cadaverine and tyramine seem to be toxic in higher doses in animals, but the individual
sensitivity to these compounds in humans varies considerably and causes different responses.
In coffee, biogenic amines originate from the action of microbial enzymes on amino acids
during fermentative processes, suggesting inappropriate storage or low-quality defective
fermented seeds. Roasting may deconjugate and increase the amount of some free biogenic
amines, whilst most other amines are degraded (Gloria and Engeseth, 2017b; Farah, 2012).
3 Main beneficial health effects of coffee
The role of coffee drinking for the purpose of socialization and relaxation is indirectly
important for health, as stress plays a major role in the development of several diseases
that may lead to serious complications and death. Additionally, coffee has been shown
to help prevent degenerative disorders, many of which are related to neurostimulating,
antioxidant and anti-inflammatory effects. A prospective US cohort study (Freedman et al.,
2012) examined the association of coffee drinking with subsequent cause-specific and
total mortality in the National Institutes of Health– AARP Diet and Health Study. This study
involved more than 400 000 people and is, so far, the largest human study investigating
coffee and health. A significant inverse association between coffee and specific deaths
due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes and
infections was found (all of which are amongst the 10 leading causes of death, WHO,
2017–Fig.1). Total mortality was reduced considerably by up to 16% for both men and
women who drank 4–5 cups of coffee a day. Similar associations were observed whether
participants drank predominantly caffeinated or decaffeinated coffee (Folmer et al., 2017).
Although scientific studies can link certain compounds to specific mechanisms, it is likely
that most contributions to decreasing the risk of certain diseases are caused by synergistic
or additive effects with various compounds present in coffee. The next section presents
summaries of research results on the effect of coffee and health, exploring the most
studied effects individually.
3.1 Coffee consumption for mental and physical performance
and well-being
The stimulating effect of coffee is well known and is due to caffeine’s ability to enhance
mental performance, which includes enhancing alertness and perception (Einother and
Giesbrecht, 2012). According to the EFSA, who reviewed existing evidence of caffeine
on mental performance (EFSA 2045, 2011c), generally, a dose of 75 mg is required to
obtain these effects, although very large differences in individual responses to caffeine
are observed. Caffeine consumption can also improve other functions such as memory
(Nehlig, 2010; Borota et al., 2014) and mood (Smith, 2005; Olson et al., 2010). Coffee
components other than caffeine have also been shown to influence cognitive performance
in an elderly population, though to a smaller extent than caffeine. Decaffeinated coffee
enriched in chlorogenic acids can improve alertness and reduce headaches and mental
Nutritional and health effects of coffee
14
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
fatigue in comparison to non-enriched decaffeinated coffee. The effects may be partly
attributed to chlorogenic acids, but other compounds naturally present in coffee are also
suggested to play a role (Camfield et al., 2013; Cropley et al., 2012; Folmer et al., 2017).
The large inter-individual variability of the stimulating effects of caffeine is due to the
difference in the ability to metabolize and eliminate it from the body. Whilst for most
people, it takes about three to six hours to eliminate 50–75% of the caffeine and its
metabolites (Goldstein, 2010), for some people, it can take much longer. The effects
of several cups of coffee on these individuals, usually called ‘slow metabolizers’, may
therefore be accumulative for a while. The variability in the enzymatic breakdown of
caffeine may account for its variable effect on sleep induction and arousal (Youngberg
et al., 2011). The stimulating effects of caffeine tend to be stronger when the individual is
in a state of fatigue or in elderly people (van Boxtel and Schmitt, 2004). However, habitual
caffeine consumers may suffer less from these issues as they develop a tolerance. In this
case, caffeine will, for example, still disrupt their sleep, but to a lesser extent than for
people who are not habitual consumers (Childs and de Wit, 2012; Drapeau, 2006). It is the
responsibility of each person to pay attention to his or her response to caffeine intake at
different times of the day, and adapt intake patterns accordingly.
Coffee and other caffeine vehicles have been used by athletes for a long time, and
the initial papers discussing the mechanisms involved date back to 1978 (Costill, 1978).
More specifically, caffeine exerts a positive effect on the endurance and exercise capacity,
due to the effect on neural mechanisms (Spriet and Gibala, 2004;Folmer et al., 2017).
Caffeine also seems to reduce the pain perception due to an increase in the secretion
of β-endorphins which exhibit analgesic properties (O’Connor et al., 2004). It is well
documented that caffeine can enhance endurance and coordination, stop–go events (e.g.
team and racket sports) and sports involving sustained high-intensity activity lasting from
Figure 1 The ten leading causes of death in the world by percentage (data from WHO, 2017, updated
in 2014).
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 15
1 min up to an hour (e.g. swimming, rowing and running races) (Jenkins, 2008; Hogervost
et al., 2008; Folmer et al., 2017).
Based on the scientific studies, the active dose of caffeine was found to be 3 mg per kg
of bodyweight, to be taken 1 h before exercise (EFSA, 2054, 2011c; Goldstein et al., 2010).
For a person weighing about 70 kg, this amount would thus be equivalent to 210 mg.
According to the EFSA caffeine safety report (EFSA 4102, 2015a), it is safe to consume
single doses of 200 mg of caffeine less than 2 h prior to intense exercise. However, the
amount and time prior to exercise for an optimal effect will vary for different individuals
due to differences in metabolic rates (Folmer et al., 2017). In 1994, caffeine was removed
from the list of banned substances.
The impact of caffeine on the mental and physical health of women and children is
a more recent area of interest, even if the initial papers appeared in the early 1990s.
Evidence suggests that the normal hormonal changes during pregnancy slow the body’s
ability to metabolize caffeine. Therefore, a given dose of caffeine can have longer-lasting
effects (as long as 15 h in the third trimester) (Kuczkowski, 2009). Even though the EFSA
report on caffeine safety (EFSA 4102, 2015a) concludes that its consumption is safe
for pregnant and lactating women, it recommends an intake reduction to a maximum
of 200 mg throughout the day. Based on scientific findings, there is no risk of adverse
birth weights for caffeine consumption below these values. Nevertheless, the risks of very
high intake (more than 600 mg of caffeine per day) include foetal growth retardation and
low weight for gestational age (Sengpiel et al., 2013). Although there is no consensus in
studies suggesting that caffeine could delay the time of conception, it may be prudent for
women who have difficulty in conceiving to limit the caffeine intake to less than 300 mg
per day (Higdon and Frei, 2006; Folmer et al., 2017).
It is known that caffeine is present in the milk of lactating coffee drinkers with a peak
appearing about 1 h after consuming a caffeinated beverage (Stavchansky et al., 1988;
Nehlig and Debry, 1994). For this reason, doctors recommend that breastfeeding women
keep caffeine intake below 200 mg per day (EFSA 4102, 2015a). At these levels, studies
show that the sleep time of nursing infants is similar to controls (Santos et al., 2012; Clarc
and Landholt, 2016; Folmer et al., 2017).
When it comes to children and coffee consumption, there are major cultural differences
in both overall coffee consumption and consumption guidelines. For example, in most
European countries, habitual coffee consumption starts when children become adults, and
until the age of 10, chocolate and tea are the main sources of caffeine (EFSA 4102, 2015a).
Brazil has implemented an active coffee school programme based on the findings that
20% coffee added to a glass of whole milk helps children perform better in school (ABIC,
2016). Additionally, there are studies that show that caffeine may attenuate the symptoms
of attention-deficit syndrome (Garfinkel et al., 1981). European adolescents consume less
coffee and their source of caffeine intake is widely distributed amongst different types
of food and beverages (EFSA 4102, 2015a). In the United States, this section of the
population primarily consumes caffeine from soft drinks (USDA, 2015).
As information on the impact of caffeine on the health of children and adolescents is
scarce, it is difficult to derive general conclusions on safe intake levels. Caffeine doses of
about 1.4 mg per kg bodyweight or more may impact sleep quality in adults, particularly
when consumed close to bedtime (EFSA 4102, 2015a). For this reason, and because data
on safe habitual caffeine intake for children and adolescents are insufficient, the EFSA
suggests a limit of 3 mg of caffeine per kg of bodyweight per day (EFSA 4102, 2015a),
which would equal around 90 mg for a 10-year old (Folmer et al., 2017).
Nutritional and health effects of coffee
16
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Canadian authorities are more conservative and suggest a limit of 2.5 mg per kg of
bodyweight per day (Health Canada, 2011). The short-term risk associated with children
and caffeine consumption is that caffeine may cause anxiety and nervousness (Nawrot
et al., 2003).
3.2 Coffee and cognitive health
The acute effects of caffeine were discussed in the mental performance section. In this
section, we will look at the long-term effects of coffee on reducing the risk of cognitive
degenerative diseases. Cognitive functions such as verbal ability, inductive reasoning and
perceptual speed decrease after 20 years of age. Genetics, life events and lifestyle factors
impact the rate and amplitude of this decline (Hedden and Gabrieli, 2004; Folmer et al.,
2017). A large number of epidemiological studies relate the regular consumption of coffee
to a reduced appearance of cognitive decline in the elderly (Arab et al., 2013; Ritchie,
2007; Corley, 2010). A meta-analysis of these human studies suggests that there is a clear
protective effect of caffeine consumption, rather than from coffee itself (Santos et al.,
2010; Ryan, 2002).
Alzheimer’s disease is the most frequent cause of dementia, leading to a progressive
cognitive decline. Whilst there is currently no medication for Alzheimer’s disease (Waite,
2015), there are studies that show an inverse association between the coffee consumption
and the development of Alzheimer’s disease, with a 27% risk reduction (Barranco Quintana
et al., 2007; Waite, 2015; Folmer et al., 2017). The mechanism is believed to be related to the
anti-inflammatory effect of caffeine on the A1 and A2 receptors, in addition to reducing the
deposits of toxic beta-amyloid peptide in the brain, a pathological characteristic in patients
with Alzheimer’s disease (Rosso, 2008; Arendash and Cao, 2010). In addition to caffeine,
the intake of polyphenols also seems to help decrease the risk of Alzheimer’s disease.
Emerging evidence from animal models also links chlorogenic acids to the prevention of
neurodegenerative disease and ageing (Esposito et al., 2002; Ramassamy, 2006). Although
the involvement of coffee polyphenols in the human cognitive function has not been well
studied, the number of findings on the in vitro neuroprotective effects of polyphenols in
general is rapidly increasing (Lakey-Beitia, et al., 2015). Initial indications relate the anti-
inflammatory effects of polyphenols to the reduced risk of developing Alzheimer’s disease.
Other proposed mechanisms could be i) inhibition of the enzymes acetylcholinesterase
and butyrylcholinesterase in the brain, as this retards acetylcholine and butyrylcholine
breakdown and ii) the prevention of oxidative stress–induced neurodegeneration due to its
high antioxidative activity (Oboh et al., 2013, Folmer et al., 2017).
Similar to Alzheimer’s disease, a large number of epidemiological studies have reported
an inverse relationship between the caffeine consumption and the risk of developing
Parkinson’s disease. The latter is a neuropathological disorder that slows down the
motor function, whilst generating resting tremors, muscular rigidity, gait disturbances
and impairing postural reflex. It involves the degeneration of neurons in the brainstem
(Kuwana et al., 1999). Coffee consumption appears to reduce, or delay, the development
of Parkinson’s disease. From the meta-analysis of 26 studies, a 25% lower risk of Parkinson’s
disease was found in coffee drinkers compared with non-coffee drinkers. The mechanism
is probably related to the capacity of caffeine to block the A2 adenosine receptors in the
brain (Costa et al., 2010). Studies recently outlined a possible additional mechanism. A
rodent model showed that trigonelline may exert a neuroprotective effect, inducing a
significant reversal of motor dysfunction (Nathan et al., 2014; Folmer et al., 2017).
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 17
3.3 Coffee and cardiovascular disease
One of the misinterpretations linking coffee and health stemmed from the belief that
the risk of cardiovascular disease, the leading cause of death in the world according to
the WHO (13.2% and 2% of deaths due to ischaemic and hypertensive cardiovascular
diseases, respectively, WHO, 2017;Fig.1), was increased by drinking coffee. This belief was
supported by the fact that caffeine increases blood pressure and acutely reduces insulin
sensitivity after coffee consumption. However, it is now known that most acute caffeine
effects cease to exist with regular coffee consumption due to adaptation mechanisms
and that other coffee components, mainly chlorogenic acids and trigonelline, have
compensatory effects on endothelial dysfunction and insulin resistance. Additionally,
in vitro and animal studies indicate that coffee has high antioxidant and anti-inflammatory
potential, improves endothelial dysfunction and reduces insulin resistance, which are key
mechanisms for cardiovascular protection (Rebello and Van Dam, 2013).
Corroborating these findings, dozens of studies have shown the inverse association
between coffee consumption and cardiovascular diseases. Andersen et al. (2006)
studied the relationship of coffee drinking with total mortality and mortality attributed to
cardiovascular disease, cancer and other diseases with a major inflammatory component.
A total of 41 836 postmenopausal women aged 55–69 years at baseline were followed
for 15 years. During this period, there were 4265 deaths. Evaluating the causes of
mortality, the authors observed that coffee consumption increasingly reduced the risk
of cardiovascular and other inflammatory diseases in postmenopausal women, thereby
decreasing mortality from these diseases. This effect was attributed to the ability of coffee
to inhibit inflammatory processes via its antioxidative and anti-inflammatory compounds.
A meta-analysis was carried out by Crippa et al. (2014), using 21 prospective studies,
with 997 464 participants and 121 915 reported deaths. Results indicated that coffee
consumption is inversely associated with all-cause and cardiovascular disease mortality
and that the risk was increasingly reduced for those who consumed 3 to 4 cups. Similar
results were observed by Malerba et al. (2013).
Another recent study by Ding et al. (2015) examined the causes of death of 19 524
women and 12 432 men from two large cohort studies in the United States, the Harvard
Health Professionals Follow-up Study and the Nurses’ Health Study (1 and 2). Inverse
associations were observed between the consumption of regular and decaffeinated coffee
and the deaths due to cardiovascular and neurological diseases. When restricting to those
that had never smoked, the all-cause mortality risk was also increasingly reduced as the
number of cups increased; however, higher consumption reduced the benefit somewhat.
Stroke is the second leading cause of death in the world as estimated by the WHO
(11.9% of the total deaths, WHO, 2017; Fig.1); however, data on the association between
coffee consumption and risk of stroke are scarce. A study by Lopez-Garcia (2009)
analysed data from a prospective cohort of 83 076 women in the Nurses’ Health Study for
24 years. Results evidenced that long-term coffee consumption is not associated with an
increased risk of stroke in women. In contrast, data suggested that coffee consumption
may modestly reduce this risk. Decaffeinated coffee was associated with a trend towards
a lower risk of stroke after adjustment for caffeinated coffee consumption. Using data
from 11 prospective studies with 479 689 participants and 10 003 cases of stroke, a meta-
analysis performed by Larsson and Orsini (2011) corroborated the results obtained for
women, finding an inverse, although modest, association between moderate coffee
consumption and risk of stroke.
Nutritional and health effects of coffee
18
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
3.4 Coffee and type2 diabetes
Diabetes mellitus is characterized by a high blood glucose level, which can cause
complications such as cardiovascular diseases, stroke, chronic kidney failure, foot ulcers
and damage to the eyes (IDF, 2012). There are three main types of diabetes: type 1, in
which the pancreas fails to produce enough insulin and which is generally genetically
determined; type 2 diabetes is the seventh leading cause of death in the world (2.7%
of the universal deaths, WHO, 2017), starts with insulin resistance (lack of insulin may
also develop) and is promoted by obesity and a sedentary lifestyle (Coope et al., 2015);
and gestational diabetes, an often transient disease that occurs when pregnant women
develop a high blood sugar level (IDF, 2015; Folmer et al., 2017).
Floegel et al. (2012) investigated the association between the coffee consumption
and the risk of chronic diseases, including type 2 diabetes. They used data from 42 659
participants collected over 8.9 years from the European Prospective Investigation into
Cancer and Nutrition (EPIC) cohort. They found an inverse association of consumption of
more than 4 cups (150 mL) of regular coffee per day with the overall risk of type 2 diabetes.
A number of similar studies have observed such effects related to regular coffee
drinking. A recent meta-analysis of large epidemiological studies confirmed the link
between moderate coffee consumption and a reduced risk of developing type 2 diabetes
across different populations (Ding et al., 2014). The findings from these systematic studies
demonstrate a clear inverse association between the coffee consumption and the risk of
developing diabetes. Compared with no, or infrequent, coffee consumption, the risk of
developing type 2 diabetes was reduced linearly, with a 33% reduction for 6 cups per
day. In a similar comparison, drinking up to four cups per day of decaffeinated coffee was
associated with a 20% reduced risk (Ding et al., 2014). This suggests that the protective
effects of coffee on diabetes are independent of caffeine.
Animal studies have indicated that the main compounds responsible for the protective
effect are chlorogenic acids (Kempf, 2010) and its derivatives, as well as trigonelline (van
Dijk et al., 2009; Rios et al., 2015). They appear to preferentially target hepatic glucose
metabolism by improving insulin sensitivity (Lecoultre et al., 2014). Other proposed
mechanisms observed in in vivo and in vitro studies include the regulation of key enzymes
of glucose and lipid metabolism, such as glucokinase, glucose-6-phosphatase, fatty acid
synthase and carnitinepalmitoyltransferase (Waite, 2015). In a human study, trigonelline
generated significantly lower glucose and insulin levels after an oral glucose load
compared with a placebo (Rios et al., 2015).
3.5 Coffee and liver diseases
There are a number of diseases that can impact liver health and include both liver cancer
and cirrhosis, a progressive disease caused by liver steatosis (fatty liver) and alcohol abuse,
where the healthy tissue is replaced by the scar tissue and eventually prevents the liver
from functioning correctly (Saab et al., 2014). According to a recent meta-analysis of 16
human studies, coffee consumption reduces the risk of developing liver cancer by 40%
compared with no coffee consumption (Larsson and Wolk, 2007; Bravi et al., 2013).
In a clinical study performed in Brazil, caffeine consumption greater than 123 mg per
day was also associated with reduced hepatic fibrosis (Machado et al., 2014). In addition,
the study observed positive effects of regular coffee consumption in patients with chronic
hepatitis C.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 19
A number of in vitro studies have demonstrated the strong role of the chlorogenic
acids present in coffee in protecting the liver from damage at various levels, possibly by
preventing cell apoptosis and oxidative stress damage due to the activation of the body’s
natural antioxidant and anti-inflammatory systems (Ji et al., 2013). Coffee melanoidins have
also been reported to have a protective effect on liver steatosis in obese rats (Vitaglione
et al., 2012), which suggests that the melanoidins in coffee may have an influence on liver
fat and functionality. Although melanoidins do not seem to be absorbed in humans, they
can function as an antioxidant dietary fibre, like the unabsorbed portion of chlorogenic
acids, quenching radicals and improving the reduced/oxidized glutathione balance in
the colon. At the same time, they may act to promote the growth of a beneficial colon
microbiota, affecting inflammatory pathways in the colon and consequently in the liver
(Folmer et al., 2017).
3.6 Coffee and cancer
In the broadest sense, cancer represents the final result of abnormal cell growth and can
occur in most human tissues. The carcinogenicity of coffee drinking was assessed by the
IARC in 1991. At that time, coffee was classified as ‘possibly carcinogenic to humans’
(Group 2B), based on limited evidence of an association with cancer of the urinary bladder
from case-control studies, and inadequate evidence of carcinogenicity in experimental
animals. When subsequent studies were controlled for smoking, they failed to show an
elevated risk of bladder cancer (Butt and Sultan, 2011). Recently, the IARC re-evaluated
the carcinogenicity of drinking coffee and other hot beverages (Loomis et al., 2016), using
a much larger database of more than 1000 observational and experimental studies. In
assessing the accumulated epidemiological evidence, more weight was given to well-
conducted prospective cohort and population-based case-control studies that controlled
adequately for important potential confounding factors, including smoking (tobacco) and
alcohol consumption. In conclusion, there was no consistent evidence associating drinking
coffee with bladder cancer. In contrast, for endometrial cancer, the five largest cohort studies
showed mostly inverse associations with coffee drinking. These results were supported by
the findings of several case-control studies and a meta-analysis. Inverse associations with
coffee drinking were also observed in cohort and case-control studies of liver cancer in
Asia, Europe and North America. A meta-analysis of prospective cohort studies estimated
that the risk of liver cancer decreases proportionally with coffee intake. No association or
a modest inverse association for female breast cancers was found. Similarly, no association
was found for pancreas and prostate cancers. Data were also available for more than 20
other cancers, including lung, colorectal, stomach, oesophageal, oral cavity, ovarian and
brain cancers and childhood leukaemia. Although the volume of data for some of these
cancers was substantial, evidence was inadequate for all the other cancers reviewed for
reasons including inconsistency of findings across studies, inadequate control for potential
confounding factors, potential for measurement error, selection bias or recall bias or
insufficient numbers of studies (Loomis et al., 2016). As a result of this re-evaluation, coffee
was upgraded by the IARC and is no longer considered to be potentially carcinogenic.
In summary, epidemiological data demonstrated that coffee consumption is actually
associated with a lower overall risk of cancer, especially liver and endometrial cancers.
There are several compounds in coffee that have been found to play a protective role
against cancer, and the most well-known are chlorogenic acids and their derivatives. The
contribution of melanoidins has also been suggested to decrease the risk of colon cancer
Nutritional and health effects of coffee
20
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
(see chlorogenic acids and melanoidins topics in this chapter). Based on in vitro and animal
evidence, coffee diterpenes are also strong candidates.
Epidemiologic studies have shown an increased risk of oesophageal cancer from
drinking hot beverages such as maté, tea or coffee. It has been observed that the intra-
oesophageal temperature is increased by 6–12°C when coffee was drunk at 65°C (Islami
et al., 2009). The high-temperature injures the oesophageal mucosa and consequently
causes inflammation or forms reactive nitrogen species, a type of free radical. It has been
suggested by the IARC that drinking coffee, and other hot beverages, at temperatures
above 65°C increases the risk of oesophageal cancer (Loomis et al., 2016). Although in
some countries, coffee is consumed at temperatures below 65°C, in other countries, the
temperature can be much higher. In public places, serving coffee at very high temperatures
may influence people to drink it hotter than they would at home, so people should be
aware of this factor for all hot beverages, soups and hot foods in general.
4 Potential side effects of coffee drinking
4.1 Hyper stimulation and sleep quality and duration by caffeine
Caffeinated coffee can cause irritability and anxiety, and reduce sleep quality by increasing
the time required to fall asleep, interfering with the depth of sleep and reducing the total
time spent sleeping. It can also cause more frequent awakening or sleep fragmentation
(Folmer et al., 2017; Clarc and Landholt, 2016; Huang et al., 2011). The use of caffeine
in energy drinks, and the risk of overdosing in children, motivated health authorities to
evaluate and publish guidelines on safe caffeine consumption. The most recent report
is the EFSA’s 2015 scientific opinion on caffeine safety (EFSA 4102, 2015a). National
health authorities have also published reports like the US Department of Agriculture
report (2015). The general agreement is that the habitual consumption of up to 400 mg
of caffeine per day, and up to 200 mg per serving, does not cause safety concerns for
non-pregnant adults. Considering a range between 100 and 200 mg caffeine per cup, this
would translate into 2–4 cups per day.
4.2 Caffeine tolerance, dependence and withdrawal
Caffeine is the most widely used psychoactive substance in the world, and the issue of
possible dependence on caffeine has been discussed for many years. In fact, different
drugs affect different people in different ways, and caffeine is no exception. It is therefore
difficult to make general statements on dependence, tolerance and withdrawal; however,
there is no such brain circuit that links caffeine to dependence. Caffeine does not affect
areas involved in reinforcing and rewarding (Nehlig, 2010). According to the standard for
measuring any potential drug abuse and dependence (as defined by the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV, American Psychiatric Association, 2000),
there are no criteria that qualify caffeine for potential drug abuse (Folmer et al., 2017).
As with any drug, regular caffeine users will establish a partial tolerance to caffeine.
However, studies have shown that this tolerance only applies to effects such as jitteriness,
anxiety and an increased heart rate. Users do not develop a tolerance to the benefits of
caffeine consumption such as improved mental performance, although sometimes slightly
higher doses of caffeine are required (Satel, 2006).
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 21
The types of caffeine withdrawal symptoms which are most often reported are
headaches; feelings of weariness, weakness and drowsiness; impaired concentration;
fatigue and work difficulty; depression; anxiety; irritability; increased muscle tension and
occasional tremors, nausea or vomiting. Withdrawal symptoms generally peak 20–48 h
after the last caffeine was consumed, although users can generally avoid these if caffeine
consumption is progressively decreased (Nehlig, 2010; Folmer et al., 2017).
Excessive coffee intake does not cause organic toxicity, but it can generate negative
side effects, such as those associated with caffeine withdrawal. Symptoms related to the
toxicity of coffee can occur at levels well below fatal doses; for example, concentrations
above 15 mg caffeine per kg of bodyweight may be toxic for the cardiovascular, nervous
and gastrointestinal systems (e.g. 1 g of caffeine for a person weighing 70 kg). Although
such caffeine levels are not easily obtained through acute coffee intake, users may easily
consume caffeine pills in such quantities. Reported overdose symptoms are hypertension
or hypotension, tachycardia, vomiting, fever, delusion, hallucinations, arrhythmia, cardiac
arrest, coma and death. Fatalities most commonly result from seizures and cardiac
arrhythmias at plasma levels of 100–180 µg per mL (Childs and de Wit, 2012; Folmer et al.,
2017). However, caffeine-related deaths have not been associated with coffee drinking
(Yamamoto, 2015).
4.3 Cholesterol-raising effects of diterpenes
Epidemiologic and mechanistic studies have reported that the diterpenes, cafestol, and
to a lesser extent, kahweol, naturally found in coffee oil and in unfiltered coffees, can
alter lipid enzymes and thus influence cholesterol levels. This relationship was found to
be linear with increasing cafestol consumption (Urgert and Katan, 1997). A meta-analysis
of a set of 18 clinical intervention trials on coffee consumption and cholesterol and serum
lipids was performed by Jee et al. (2001). The authors corroborated the dose–response
relationship between coffee consumption and cholesterol and observed a strong increase
upon the consumption of 6 or more cups of boiled coffee per day, which was not observed
when a paper filter was used.
The high consumption of diterpenes has been associated with elevated homocysteine
and low-density lipoprotein levels in human plasma, which may indirectly increase the risk
of cardiovascular diseases (Farah, 2012).
4.4 Gastro-oesophageal reflux or heartburn
Gastro-oesophageal reflux, also called heartburn, is caused by the reflux of gastric fluid
into the oesophagus due to the low pressure in the sphincter muscle at the junction of
the stomach and oesophagus. A number of people suffering from this condition have
mentioned that coffee may be one of the food products causing this complaint. Although
some studies have tried to investigate this, the role of coffee consumption in reflux is still
unclear. It has, for example, been reported that a few compounds in coffee stimulate the
production of gastric juice, which is very acidic when first produced in the stomach (pH
1–2). Chlorogenic acids, Nβ-alkanoil-5-hydroxytryptamides (C5HTs) from coffee wax, and
to a lesser extent, caffeine, are some of the main compounds thought to promote this
effect (Fehlau and Netter, 1990). Additionally, it has been hypothesized that the roasting
products of chlorogenic acid such as pyrogallol, like C5HTs, irritate the gastric mucosa
(Darboven, 1997). In addition to the stimulation of gastric juice, coffee consumption also
Nutritional and health effects of coffee
22
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
seems to cause muscle contraction impairment (relaxation effect) of the lower oesophageal
sphincter in some individuals, promoting heartburn, which has been attributed to caffeine
(Terry et al., 2000). The pH of a coffee brew is mildly acidic, commonly fluctuating between
5.8 and 5.5 in robusta coffees and between 4.3 and 4.8 in fresh lightly roasted acidic
arabica coffees, with approximately pH 5.0 being more usual in dark roasted blends. This
is much higher than the pH of gastric juice or, for example, the pH of apple juice (pH
4.3–3.3) or citric juice (pH 2.3–3.3) (Farah, unpublished).
Therefore, based on current knowledge, the stimulation of gastric juice production
along with the relaxation of the oesophageal sphincter seems to be the most likely causes
for heartburn, although some studies support the contribution of the acidity of foods
to heartburn (Feldman and Barnett, 1995). Since there are only a few studies on this
subject and none in humans, more mechanistic and clinical studies are necessary to prove
the involvement of each of these specific coffee compounds in this disease, as well as
improving conditions in their absence.
Some pre-roasting technological methods have been developed which aim to decrease
heartburn, although no clinical studies have yet proved that these treatments are effective
in humans. Reducing coffee wax, and thus C5HTs, can be achieved by applying steam
treatment, either as a stand-alone process, or as part of the water or CO2 decaffeination
methodologies (which in addition decreases the content of chlorogenic acids and caffeine).
5 Final considerations
Since the initial studies published in medical journals in the eighteenth century, coffee
has been through many waves of approval and disapproval. As science has evolved and
confounding factors could be accounted for, an increasing number of studies have found
correlations between coffee consumption and reduced risk of developing certain diseases.
As in vitro and animal studies confirm the involvement of active coffee components in
specific diseases, the challenge remains to fully understand the mechanisms that these
active compounds exert, as coffee is a molecularly highly complex beverage made up of
thousands of compounds. It is, however, becoming more evident that it is not only the
specific compounds in coffee, but rather the beverage as a whole that is responsible for its
beneficial effects.
Despite the potentially positive contribution of coffee to reducing the risk of certain
diseases, these findings need to be related to each other and, more importantly, to
lifestyle factors that influence the risk of developing certain diseases and longevity. Some
of these include not smoking, good nutrition (a balanced and varied diet including five
servings of fruit and vegetables daily), exercise, low alcohol consumption and low stress,
all of which have a strong documented impact on disease prevention and life expectation
(Khaw et al., 2008).
6 Acknowledgements
The author would like to thank Britta Folmer, from Nestlé Nespresso SA, for her valuable
contribution to this chapter. The Research scholarships provided by the Brazilian National
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 23
Council for Scientific and Technological Development – CNPq and the Research Support
Foundation of Rio de Janeiro – FAPERJ are greatly appreciated.
7 Where to look for further information
7.1 Recommended books
Folmer, B. (Ed). (2017). The Craft and Science of Coffee. Elsevier, London,1st edition.
Farah, A. (Ed). (2017). Coffee: Chemistry Quality and Health Implications. Royal Society of
Chemistry, UK, 1st edition, In press.
Preedy, V. (Ed). (2015). Coffee in Health and Disease Prevention. Elsevier, London, UK, 1st
edition.
Feng, I. (2012). Coffee: Emerging Health Effects and Disease Prevention. IFT Press/Willey-
Blackwell, USA.
7.2 Recommended websites
• International coffee organization (ICO): www.ico.org. The International Coffee
Organization (ICO) is the main intergovernmental organization for coffee, bringing
together producing and consuming countries to tackle the challenges faced by
the world coffee sector through international cooperation. It makes a practical
contribution to the world coffee economy and to improving the standards of living in
developing countries by enabling government representatives to exchange views and
coordinate coffee policies and priorities, and enabling government representatives
to exchange views and coordinate coffee policies and priorities at regular high level.
On this site, in addition to the information on world coffee production, exports and
imports, general global information on coffee is also found.
• Association for Science and Information on Coffee (ASIC): www.asic-cafe.org. ‘ASIC
is a completely independent organization in the world whose scientific vocation is
specifically devoted to the coffee tree, the coffee bean and the coffee drink’. On ASIC’s
site, you will find the proceedings of the previous colloquia as well as information and
links on the latest publications on coffee agronomy, chemistry, technology, coffee
and health and physiological effects of coffee.
• The Specialty Coffee Association (SCA) that is a membership-based association acts
as a unifying force within the specialty coffee industry and works to make coffee better
by raising standards worldwide through a collaborative and progressive approach.
Members of the SCA include coffee retailers, roasters, producers, exporters and
importers, as well as manufacturers of coffee equipment and related products. For
more information, access www.sca.coffee.The SCA was formed in January 2017
following the merger of the SCAA and SCAE, acting in the United States and Europe.
The respective websites are currently still active and information on training, education,
events and standards can still be found (seewww.scaa.org and www.scae.org)
• A website fully dedicated to entire information on coffee and health is www.
coffeeandhealth.org. It is a science-based resource developed for health care and
other professional audiences and provides the latest information and research into
coffee, caffeine and health.
Nutritional and health effects of coffee
24
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
8 References
ABIC, 2016 http ://abic.com.br/institucional/projetos-sociais/ accessed dez, 2016 and 2017.
Alcázar, A., Fernández-Cáceres, P. L., Martın-Valero, M., Pablos, F. and González, A. G., 2003. Ion
chromatographic determination of some organic acids, chloride and phosphate in coffee and
tea. Talanta, Amsterdam 61(1), 95–101.
American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th
Ed. American Psychiatric Association, Arlington, VA.
Antonio, A. G., Moraes, R. S., Perrone, D., Maia, L. C., Santos, K. R. N., Iório, N. L. P. and Farah, A.,
2010. Species, roasting degree and decaffeination influence the antibacterial activity of coffee
against Streptococcus mutans. Food Chemistry 118, 782–8.
Andersen, L. F., Jacobs Jr., D. R., Carlsen, M. H. and Blomhoff, R., 2006. Consumption of coffee is
associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in
the Iowa Women’s Health Study. American Journal of ClinicalNutrition 83(5), 1039–46.
Arab, L., Khan, F’ and Lam, H., 2013. Epidemiologic evidence of a relationship between tea, coffee,
or caffeine consumption and cognitive decline. Advances in Nutrition 4(1), 115–22.
Arauz, J., Rivera-Espinoza, Y., Shibayama, M. and Muriel, P., 2015. Nicotinic acid prevents experimental
liver fibrosis by attenuating the prooxidant process. International Immunopharmacology 28(1),
244–51.
Arendash, G. W. and Cao, C., 2010. Caffeine and coffee as therapeutics against Alzheimer’s disease.
Journal of Alzheimer’s Disease 20(S1), 117–26.
Balzer, H. H., 2001. Acids in coffee. In: Coffee Recent Developments (Clarke, R. J. and Vitzthum, O.
G. (Eds). Blackwell Science, Berlin, p. 18.
Barranco Quintana, J. L., Allam, M. F., SerranoDel Castillo, A. and Fernandez-Crehuet Navajas, R.,
2007. Alzheimer’s disease and coffee: A quantitative review. Neurological Research 29, 91–5.
Bizzo, M. L. G., Farah, A., Kemp, J. A. and Scancetti, L. B., 2015. Highlight in the history of coffee
science related to health. In: Coffee in Health and Disease Prevention (Preedy, V. (Ed.)). Elsevier,
London, UK, pp.11–18.
Borrelli, R. C., Esposito, F., Napolitano, A., Ritieni, A. and Fogliano, V., 2004. Characterization of a new
potential functional ingredient: Coffee silverskin. Journal of Agriculture and Food Chemistry 52,
1338–43.
Boekshoten, M.V., Van Cruschten, S.T., Kosmeijer-Schuil, T.G. and Katan, M.B. 2006. Negligible
amounts of cholesterol-raising diterpenes in coffee made with coffee pads in comparison with
unfiltered coffee, 2006. Nederlands Tijdschrift voor Geneeskunde, 150, 2873–5.
Borota, D., Murray, E., Kecell, G., Chang, A., Watabe, J. M., Ly, M., Toscano, J. P. and Yassa, M.A.,
2014. Post-study caffeine administration enhances memory consolidation in humans. Nature
Neuroscience 17, 201–3.
Bravi, F., Bosetti, C., Tavoni, A., Gallus, S. and La Vecchia, C., 2013.Coffee reduces risk for hepatocellular
carcinoma: An updated meta-analysis. Clinical Gastroenterology and Hepatology 11, 1413–21.
Butt, M. S. and Sultan, M. T., 2011. Coffee and it’s Consumption: Benefits and Risks. Critical Reviews
in Food Science and Nutrition 51, 363–73.
Camfield, D. A., Silber, B. Y., Scholey, A. B., Nolidin, K., Goh, A. and Stough, C., 2013. A Randomised
placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic
acid from decaffeinated coffee. Public Library of Science One 8(12), e82897.
Carpenter, K. J., 1983. The relationship of pellagra to corn and the low availability of niacin in cereals.
Experientia Suppl. 44: 197–222.
Casal S., 2017. Potential effects of β-carbolines on human health. In Coffee: Chemistry, Quality, and
Health Implications (Farah, A. (Ed.)). Royal Society of Chemistry, London, UK. In press.
Chang, W. H., Hu, S. P., Huang, Y. F., Yeh, T. S. and Liu, J. F., 2010. Effect of purple sweet potato
leaves consumption on exercise-induced oxidative stress and IL-6 and HSP72 levels. Journal of
Applied Physiology 109(6), 1710–15.
Childs, E. and de Wit, H., 2012. Potential mental risks. In: Coffee, Emerging Health Effects and
Disease Prevention (Chu, Y.-F. (Ed.)). Wiley-Blackwell, Oxford, UK, pp. 293–306.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 25
Clarc, I. and Landholt, H. P., 2017. Coffee, caffeine and sleep: A systematic review of epidemiological
studies and randomized controlled trials. Sleep Medicine Reviews 31, 70–8.
Cliford, M. N. 1985. Chlorogenic acids in coffee. In Chemistry, vol 1, Clarke R. J. and Macrae R. (Eds),
Elsevier Applied Science, London, 153–202.
Coope, A., Torsoni, A. S. and Velloso, L., 2015. Mechanisms in endocrinology: Metabolic and
inflammatory pathways on the pathogenesis of type 2 diabetes. European Journal of
Endocrinology 15, 1065.
Corley, J., Jia, X., Kyle, J. A., Gow, A. J., Brett, C. E., Starr, J. M., McNeill, G. and Deary, I. J. 2010.
Caffeine consumption and cognitive function at age 70: The Lothian Birth Cohort 1936 study.
Psychosomatic Medicine 72, 206–14.
Costa, J., Lunet, N., Santos, C., Santos, J. and Vaz-Cameiro, A., 2010. Caffeine exposure and the risk
of Parkinson’s disease: A systemic review and meta-analysis of observational studies. Journal of
Alzheimer’s Disease 20, S221–38.
Costill, D. L., Dalsky, G. P. and Fink, W. J., 1978. Effects of caffeine ingestion on metabolism and
exercise performance. Medicine Science in Sports 10(3), 155–8.
Crippa, A., Discacciati, A., Larsson, S. C., Wolk, A. and Orsini, N., 2014. Coffee consumption and
mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis.
American Journal of Epidemiology 180, 763–75.
Cropley, V., Croft, R., Silber, B., Neale, C., Scholey, A., Stough, C. and Schmitt, J., 2012. Does coffee
enriched with chlorogenic acids improve mood and cognition after acute administration in
healthy elderly? A pilot study. Psychopharmacology 219(3), 737–49.
Cunha, S. and Fernandes, J. 2017. Pesticides. In: Coffee: Chemistry, Quality and Health Implications
(Ed.: Farah, A.). Royal Society of Chemistry, London, UK. In press.
Darboven, A.1997. Method for the quality improvement of raw coffee by treatment with steam and
water (in German). Europaisches Patent- € blatt, 1997/05/95109295.6.
Ding, M., Satija, A., Bhupathiraju, S. N., Hu, Y., Sun, Q., Han, J., Lopez-Garcia, E., Willet, W., van
Dam. R. M. and Hu, F. A., 2015. Association of coffee consumption with total and cause-specific
mortality in three large prospective cohorts.Circulation 132(24), 2305–15.
Ding, M., Bhupathiraju, S.N., Chen, M., vanDam, R. M. and Hu, F. B., 2014. Caffeinated and
decaffeinated coffee consumption and risk of Type 2 diabetes: A systematic review and a dose-
response meta-analysis. Diabetes Care 37(2), 569–86.
Drapeau, C., Hamel-Hebert, I., Robillard, R., Seimaoui, B., Filipini, D. and Carner, J., 2006. Challenging
sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged
moderate caffeine consumers. Journal of Sleep Research 15(2), 133–41.
Einother, S. J. L. and Giesbrecht, T., 2012. Caffeine as an attention enhancer: Reviewing existing
assumptions. Psychopharmacology 225(2), 251–74.
Esposito, E., Rotilio, D., Di Matteo, V., Di Giulio, C., Cacchio, M. and Algeri, S., 2002. A review of specific
dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative
processes. Neurobiology of Aging 23, 719–35.
EFSA (European Food Safety Authority), 2008. Scientific opinion of the panel on contaminants in the
food chain on a request from the European commission on polycyclic aromatic hydrocarbons in
food. The EFSA Journal, 724, 1–114.
EFSA (European Food Safety Authority), 2011a. Scientific Opinion on Flavouring Group Evaluation
218, Revision 1 (FGE.218Rev1): alpha, beta-Unsaturated aldehydes and precursors from
subgroup 4.2 of FGE.19: Furfural derivatives. EFSA Journal 9(3), 1840.
EFSA (European Food Safety Authority), 2011b. EFSA Panel on Dietetic Products, Nutrition and
Allergies (NDA), Scientific Opinion on the substantiation of health claims related to caffeine and
increase in physical performance during short-term high-intensity exercise (ID 737, 1486, 1489),
increase in endurance performance (ID 737, 1486), increase in endurance capacity (ID 1488)
and reduction in the rated perceived exertion/effort during exercise (ID 1488, 1490) pursuant to
Article 13(1) of Regulation (EC) No 1924/20061. EFSA Journal 9(4), 2053.
EFSA (European Food Safety Authority), 2011c. EFSA Panel on Dietetic Products, Nutrition and
Allergies (NDA), Scientific Opinion on the substantiation of health claims related to caffeine and
increased fat oxidation leading to a reduction in body fat mass (ID 735, 1484), increased energy
Nutritional and health effects of coffee
26
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
expenditure leading to a reduction in body weight (ID 1487), increased alertness (ID 736, 1101,
1187, 1485, 1491, 2063, 2103) and increased attention (ID 736, 1485, 1491, 2375) pursuant to
Article 13 (1) of Regulation (EC) No 1924/20061. EFSA Journal 9(4), 2054.
EFSA (European Food Safety Authority), 2015a. EFSA panel on dietetic products, Nutrition and
Allergies (NDA), scientific opinion on the safety of caffeine. EFSA Journal 13(5), 4102.
EFSA (European Food Safety Authority), 2015b. EFSA panel on contaminants in the food chain
(CONTAM) scientific opinion on acrylamides in food. EFSA Journal 13(6), 4104.
FDA (Food and Drug Administration), 2016. FDA Guidance for Industry Acrylamide in Foods. FDA
Office of Food Safety, USA.
Farah, A. and Donangelo, C., 2006. Phenolic compounds in coffee. Brazilian Journal of Plant
Physiology 18(1), 23–36.
Farah, A., 2012. Coffee constituents. In: Chu, Y.-F. (Ed.), Coffee: Emerging Health Effects and Disease
Prevention. IFT Press/Willey-Blackwell, USA, pp. 21–58.
Fehlau, R. and Netter, K. J.1990. Effect of untreated and non-irritating purified coffee and carbonic
acid hydrytryptamides on the gastric mucosa in the rat Z. Gastroenterol, 28, 234–8.
Feldman, M. and Barnett, C., 1995. Relationships between the acidity and osmolarity of popular
beverages and reported postprandial heartburn. Gastroenterology, 108, 125–31.
Feng, R., Lu, Y., Bowman, L. L., Qian, Y., Castranova, V. and Ding, M., 2005. Inhibition of activator
Protein-1, NF-κB, and MAPKs and induction of phase 2 detoxifying enzyme activity by
chlorogenic acid. Journal of Biological Chemistry 280, 27888–95.
Ferreira, I. M. P. L. V. O., Pinho, O. and Petisca, C., 2017. Potential effects of furan and related
compounds on health. In: Coffee: Chemistry, Quality and Health Implications (Ed.: Farah, A.).
Royal Society of Chemistry, London, UK. In press.
Floegel, A., Pischon, T., Bergmann, M. M., Teucher, B., Kaaks, R, Boeing, H., 2012. Coffee consumption
and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition
(EPIC)–Germany study. American Journal Clinical Nutrition 95, 901–8.
Fogliano, V. and Morales, F. J., 2011. Estimation of dietary intake of melanoidins from coffee and
bread. Food and Function 2, 117–23.
Folmer, B., Farah, A., Fogliano, V. and Jones, L. 2017. Human wellbeing – Sociability, performance
and health. In: The Craft and Science of Coffee, 1st Ed. (Ed.: Folmer, B.). Elsevier, London, UK,
pp. 493–510.
Freedman, N., Park, Y., Abnet, C. C., Hollenbeck, A. R. and Sinha, R., 2012. Association of coffee
drinking with total and cause-specific mortality. New England Journal of Medicine 366(20),
1891–904.
Garfinkel, B. D., Webster, C. D. and Sloman, L., 1981. Responses to methylphenidate and various
does of caffeine in children with attention deficit disorder. The Canadian Journal of Psychiatry/
La Revue canadienne de psychiatrie 26(6), 395–401.
Garsetti, M., Pellegrini, N., Baggio, C. and Brighenti, F., 2000. Antioxidant activity in human faeces.
British Journal of Nutrition 84(5), 705–10.
Gebicki, J., Marcinek, A., Chlopicki S. and Adamus, J. 2008. The use of quaternary pyridinium
compounds for vasoprotection and/or hepatoprotection. Patent WO2008104920A1.
Gerson, M., 1978. The cure of advanced cancer by diet therapy: a summary for 30 years of clinical
experimentation. Physiological Chemistry and Physics 10, 449–64.
Glória and Engeseth , 2017a. Potential beneficial effects of bioactive amines on health. In:Coffee:
Chemistry, Quality, and Health Implications (Ed.: Farah, A.). Royal Society of Chemistry, London,
UK. In press.
Glória and Engeseth , 2017b. Potential adverse effects of coffee bioactive amines to human health. In
Coffee: Chemistry, Quality, and Health Implications (Ed.: Farah, A.). Royal Society of Chemistry,
London, UK. In press.
Gniechwitz, D., Brueckel, B., Reichardt, N., Blaut, M., Steinhart, H. and Bunzel, M. 2007. Coffee dietary
fiber contents and structural characteristics as influenced by coffee type and technological and
brewing procedures. Journal of Agricultural and Food Chemistry 55, 11027–34.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 27
Gniechwitz, D., Reichardt, N., Ralph, J., Blaut, M., Steinhart, H.and Bunzel, M., 2008. Isolation and
characterisation of a coffee melanoidin fraction. Journal of the Science of Food Agriculture 88,
2153–60.
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby,
D., Stout, J., Graves, B. S., Wildman, R., Ivy, J. L., Spano, M., Smith, S. E. and Antonio, J., 2010.
International society of sports nutrition position stand: Caffeine and performance. Journal of the
International Society of Sports Nutrition 7, 5.
Grembecka, M., Malinowska, E. and Szefer, P., 2007. Differentiation of market coffee and its infusions
in view of their mineral composition. Science of the Total Environment 383, 59–69.
Gross, G., Jaccaud, E. and Hugget, A.C., 1997. Analysis of the content of the diterpenes cafestol and
kahweol in coffee brews. Food and Chemical Toxicology 35, 547–54.
Health Canada, 2011. Information for Parents on Caffeine in Energy Drinks.www.hc-sc.gc.ca/fn-an/
securit/addit/caf/faq-eng.php, Accessed January 2017.
Hedden, T. and Gabrieli, J. D. E., 2004. Insights into the ageing mind: A view from cognitive
neuroscience. Nature Reviews Neuroscience 5, 87–97.
Higdon, J. V. and Frei, B., 2006. Coffee and health: A review of recent human research. Critical
Reviews in Food Science and Nutrition 46, 101–23.
Hirakawa, N., Okauchi, R., Miura, Y. and Yagasaki, K., 2005. Anti-invasive activity of niacin and
trigonelline against cancer cells. Bioscience, Biotechnology and Biochemistry 69(3), 653–8.
Hogervost, E., Bandelow, S., Schmitt, J., Jentjens, R., Oliveira, M., Allgrove, J., Carter, T. and Gleeson,
M., 2008. Caffeine improves physical and cognitive performance during exhaustive exercise.
Medicine and Science in Sports and Exercise 40, 1841–51.
Hong, B. N., Yi, T. H., Park, R., Kim, S. Y. and Kang, T. H., 2008. Coffee improves auditory neuropathy
in diabetic mice. Neuroscience Letters 441(3), 302–6.
Huang, Z., Urade, Y. and Hayaishi, O., 2011. The role of adenosine in the regulation of sleep. Current
Topics in Medicinal Chemistry 11, 1047–57.
International Agency for Research on Cancer (IARC), 2010. Some non-heterocyclic polycyclic aromatic
hydrocarbons and some related exposures. IARC Monogr Eval Carcinog Ris 1997; USDA
National Nutrient Database for Standard Reference, release 28, 2015 any Maryland, USA
International Coffee Organization, 2014. World coffee trade (1923–2013): A review of the markets,
challenges and opportunities facing the sector. 112thSession.http://www.ico.org/news/icc-111-
5-r1e-world-coffee-outlook.pdf
International Diabetes Federation (IDF), 2012. Clinical Guidelines Task Force Global Guideline for
Type 2 Diabetes.
International Diabetes Federation (IDF), 2015. Diabetes Atlas, 5th Ed. Brussels, Belgium.
Islami, F., Boffetta, P., Ren, J. S., Pedoeim, L., Khatib, D. and Kamangar, F., 2009. High-temperature
beverages and foods and esophageal cancer risk – A systematic review. International Journal of
Cancer 125(3), 491–524.
Jee, S. H., He, J., Appel, L. J., Whelton, P. K., Suh, I. and Klag, M. J., 2001. Coffee consumption
and serum lipids: A meta-analysis of randomized controlled clinical trials. American Journal of
Epidemiology 153, 353–62.
Jenkins, N. T., Trilk, J. L., Singhal, A., O’Connor, P. J. and Cureton, K. J., 2008. Ergogenic effects of low
doses of caffeine on cycling performance. International Journal of Sport Nutrition and Exercise
Metabolism 18(3), 328–42.
Ji L., Jiang, P., Lu, B., Sheng, Y., Wang, X. and Wang, Z., 2013. Chlorogenic acid, a dietary polyphenol,
protects acetaminophen-induced liver injury and its mechanism. Journal of Nutrition and
Biochemistry 24(11), 1911–19.
Jurkowska, R. Z., Jurkowski, T. P. and Jeltsch, A., 2011. Structure and function of mammalian DNA
methyltransferases. European Journal of Chemical Biology 12, 206–22.
Kalaska, B., Piotrowski, L., Leszczynska, A., Michalowsk, B., Kramkowski, K., Kaminski, T., Adamus,
J., Marcinek A., Gebicki, J., Mogielnicki A. and Buczko, W., 2014. Antithrombotic effects of
Nutritional and health effects of coffee
28
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
pyridinium compounds formed from trigonelline upon coffee roasting. Journal of Agricultural
and Food Chemistry, 62(13), 2853–60.
Kasai H., Fukada, S., Yamaizumi, Z., Sugie, S. and Mori, H. 2000. Action of chlorogenic acid in
vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in a rat
carcinogenesis model. Food and Chemical Toxicology 38, 467–71.
Kempf, K., Herder, C., Erlund, I., Kolb, H., Martin, S., Carstensen, M., Koenig, W., Sandwall, J., Bidel,
S., Kuha, S. and Tuomilehto, J., 2010. Effects of coffee consumption on subclinical inflammation
and other risk factors for type 2 diabetes: A clinical trial. American Journal of Clinical Nutrition
91, 950–7.
Khaw, K. T., Wareham, N., Bingham, S., Welch, A., Luben, R. and Day, N., 2008. Combined impact of
health behaviours and mortality in men and women: the EPIC-Norfolk prospective population
study. PLoS Medicine 5(1), e12.
Kuczkowski, K. M., 2009. Caffeine in pregnancy.Archives of Gynecology and Obstetrics 280, 695–8.
Kuwana, Y., Shiozaki, S., Kanda, T., Kurokawa, M., Koga, K., Ochi, M., Ikeda, K., Kase, H., Jackson, M.
J., Smith, L. A., Pearce, R. K. and Jenner, P. G.1999. Antiparkinsonian activity of adenosine A2A
antagonists in experimental models. Advances in Neurology, 80, 121–3.
Lachenmeier, D.W., 2015. Furan in coffee products: A probabilistic exposure estimation. In:Coffee
in Health andDiseasePrevention (Ed.:Preedy, V.). Elsevier, 1st edition. New York and London,
pp. 887–93.
Lakey-Beitia, J., Berrocal, R., Rao, K. S.and Durant, A. A., 2015. Polyphenols as therapeutic molecules
in Alzheimer’s disease through modulating amyloid pathways. Molecular Neurobiology 51(2),
466–79.
Lang, R., Wahl, A., Stark, T. and Hofmann, T.2011. Urinary N-methylpyridinium and trigonelline as
candidate dietary biomarkers of coffee consumption. Molecular Nutrition & Food Research
5(11), 1613–23.
Lang, R., Bardelmeier, I., Weiss, C., Rubach, M., Somoza, V. and Hofmann, T., 2010. Quantitation of
βN-Alkanoyl-5-hydroxytryptamides in coffee by means of LC-MS/MS-SIDA and assessment of
their gastric acid secretion potential using the HGT-1 cell assay. Journal of Agricultural and Food
Chemistry 58(3), 1593–602.
Larsson, S. C. and Wolk, A., 2007. Coffee consumption and risk of liver cancer: A meta-analysis.
Gastroenterology 132, 1740–5.
Larsson S. C. and Orsini, N., 2011. Coffee consumption and risk of stroke: a dose-response meta-
analysis of prospective studies. American Journal of Epidemiology 174(9), 993–1001
Le Bloch J. L. V., Chetiveaux M., Freuchet B., Magot T., Krempf M., Nguyen P. and Ouguerram K. 2010.
Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic
very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition
in obese dogs. The journal of Pharmacology and Experimental Therapeutics, 334, 583–89.
Lecoultre, V., Carrel, G., Egli, L., Binnert, C., Boss, A., MacMillan, E. L., Kreis, R., Boesch, C., Darimont,
C. and Tappy, L., 2014. Coffee consumption attenuates short-term fructose-induced liver insulin
resistance in healthy men. American Journal of Clinical Nutrition 99(2), 268–75.
Lipworth, L., Sonderman, J. S., Tarone, R. E. and McLaughlin, J., 2012. Review of epidemiologic
studies of dietary acrylamide intake and the risk of cancer. European Journal of Cancer
Prevention 21, 375–86.
Loomis, D., Kathryn, Z., Grosse, G. Y., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V.,et al. 2016.
Carcinogenicity of drinking coffee, mate, and very hot beverages.The Lancet Oncology
17(7),877–8.
Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K. M., Logroscino, G., Hu, F. B. and van Dam, R. M.,
2009. Coffee consumption and risk of stroke in women. Circulation 119(8),1116–23.
Ludwig, I. A., Clifford, M. N., Lean, M. E. J., Ashihara, H. and Crozier, A., 2014. Coffee: Biochemistry
and potential impact on health.Food and Function 5, 1695–717.
Machado, S. R., Parise, E. R. and Carvalho, L., 2014. Coffee has hepatoprotective benefits in Brazilian
patients with chronic hepatitis C even in lower daily consumption than in American and European
populations. Brazilian Journal of Infectious Disease 18(2), 170–6.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 29
Macrae, R., 1985. Nitrogenous compounds. In: Coffee. Volume 1 Chemistry, 1st Ed. (Ed.:Clarke, R.
J.and Macrae, R.). Elsevier, London and New York, p.115.
Malerba, S., Turati, F., Galeone, C., Pelucchi, C., Verga, F., La Vecchia, C. and Tavani, A., 2013. A meta-
analysis of prospective studies of coffee consumption and mortality for all causes, cancers and
cardiovascular diseases.European Journal of Epidemiology 28(7), 527–39.
Moreira, A., Coimbra, M., Nunes, F. M., Passos, C. P., Santos, S. A., Silvestre, A. J., Silva, A., Rangel,
M.and Domingues, M. R. M., 2015. Chlorogenic acid-arabinose hybrid domains in coffee
melanoidins: Evidences from a model system. Food Chemistry 185, 135–44.
Moura-Nunes, N., Perrone, D., Farah, A. and Donangelo, C., 2009. The increase in human plasma
antioxidant capacity after acute coffee intake is not associated with endogenous non-enzymatic
antioxidant components. International Journal of Food Sciences and Nutrition 60(supp 6),
173–81.
Mucci, L. A. and Adami, H. O., 2009. The Plight of the Potato: Is dietary acrylamide a risk factor for
human cancer?Journal of National Cancer Institute 101(9), 618–21.
Navarini, L., Colomban, S., Caprioli, G.and Sagratini, G., 2017. Isoflavones, Lignans and other minor
polyphenols. In:Coffee: Chemistry, Quality and Health Implications (Ed. Farah, A.). Royal Society
of Chemistry, London, UK. In press.
Nathan, J., Panjwani, S., Mohan, V., Joshi, V. and Thakurdesai, P. A., 2014. Efficacy and safety of
standardized extract of Trigonella foenum-graecum L seeds in an adjuvant to L-Dopa in the
management of patients with Parkinson’s disease. Phytotherapy Research 28(2), 172–8.
Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J, Hugenholtz, A. and Feeley, M., 2003. Effects of
caffeine on human health. Food Additives and Contaminants 20, 1–30.
Nehlig A. and Debry, G., 1994. Consequences on the newborn of chronic maternal consumption of
coffee during gestation and lactation: A review. Journal of the American College of Nutrition
13, 6–21.
Nehlig, A., 2010. Is caffeine a cognitive enhancer? Journal of Alzheimer’s Disease 20(S1), 85–94.
Nkondjock, A., 2012. Coffee and cancers. In:Coffee: Emerging Health Effects and Disease Prevention
(Ed.: Chu, Y.-F.). 1st edition, Wiley-Blackwell, Oxford, UK, pp. 293–306.
Nunes F. M., Coimbra M. A., Duarte A. C., and Delgadillo I., 1997. Foamability, foam stability, and
chemical composition of espresso coffee as affected by the degree of roast, J. Agric. Food
Chem., 45 (8), 3238–43.
Oboh, G., Agunloye, O. M., Akinyemi, A. J., Ademiluyi, A. O. and Adefegha, S. A., 2013.
Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes
linked to Alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in
vitro. Neurochemistry Research 38(2), 413–19.
Obuleso, M., Dowlathabad, M. R. and Bramhachari, P. V., 2011. Carotenoids and Alzheimer’s Disease:
An insight into therapeutic role of retinoids in animal models. Neurochemistry International
59(5), 535–41.
O’Connor, P. J., Motl, R. W., Broglio, S. P. and Ely, M. R., 2004. Dose-dependent effect of caffeine on
reducing leg muscle pain during cycling exercise is unrelated to systolic blood pressure. Pain
109, 291–8.
Oliveira, M., Casal, S., Morais, S., Alves, C., Dias, F., Ramos, S., Mendes, E., Delerue-Matos, C. and
Oliveira, B. P. P., 2012. Intra- and interspecific mineral composition variability of commercial
coffees and coffee substitutes. Contribution to mineral intake. Food Chemistry 130, 702–9.
Oliveira, M., Ramos, S., Delerue-Matos, C. and Morais S, 2015. Espresso beverages of pure origin
coffee: Mineral characterization, contribution for mineral intake and geographical discrimination.
Food Chemistry 177, 330–8.
Olson, C. A., Thornton, J. A., Adam, G. E. and Lieberman, H. R., 2010. Effects of 2 adenosine antagonists,
quercetin and cafeïne, on vigilance and mood. Journal of Clinical Psychopharmacology 30(5),
573–8.
Passos, C. P., Cepeda, M. R., Ferreira, S. S., Nunes, F. M., Evtuguin, D. V., Madureira, P., Vilanova,
M.and Coimbra, M. A., 2014. Influence of molecular weight on in vitro immunostimulatory
properties of instant coffee. Food Chemistry 161, 60–6.
Nutritional and health effects of coffee
30
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Petraco, M., 2005. The cup. In: Espresso Coffee: The Science of Quality, 2nd edition (Eds: Illy, A.and
Viani, R.). Elsevier Academic Press, Italy, pp. 290–8.
Quan H.Y., Kim D.Y., and Chung S.H, 2013. Caffeine attenuates lipid accumulation via activation of
AMP-activated protein kinase signaling pathway in HepG2 cells BMB Reports 46(4), 207–12.
Ramassamy, C., 2006. Emerging role of polyphenolic compounds in the treatment of neurodegenerative
diseases: A review of their intracellular targets. European Journal of Pharmacology 545, 51–64.
Ramos, S., 2008. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signaling
pathways. Molecular Nutrition and Food Research, 52, 507–26.
Rebello, S.A. and Van Dam, R., 2013. Coffee consumption and cardiovascular health: Getting to the
heart of the matter. Current Cardiology Reports 15(10), 403–5.
Riedel, A., Hochkogler C. M., Lang, R., Bytof, G., Lantz, I., Hofmann, T. and Somoza, V., 2014.
N-methylpyridinium, a degradation product of trigonelline upon coffee roasting, stimulates
respiratory activity and promotes glucose utilization in HepG2 cells. Food &Function 5(3):454–62.
Rios, J. L., Francini, F. and Schinella, G. R., 2015. Natural products for the treatment of Type 2 diabete
mellitus. Planta Medica 81(12–13), 975–94.
Ritchie, K., Carriere, I., de Mendonca, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau,
P. and Ancelin, M. L., 2007. The neuroprotective effects of caffeine. A prospective population
study. Neurology 69, 536–45.
Rodrigues, D.A.C.and Casal, S., 2017. β-Carbolines. In: Coffee, Chemistry, Quality and Health
Implications (Ed.: Farah, A.). Royal Society of Chemistry, London, UK. In Press.
Rosso, A., Mossey, J. and Lippa, C. F., 2008. Review: Caffeine: Neuroprotective functions in cognition and
alzheimer’s disease. American Journal of Alzheimer’s Disease and Other Dementias 23(5), 417–22.
Rubach M., Lang R., Bytof G., Stiebitz H., Lantz I., Hofmann T. and Somoza V. 2014. A dark brown
roast coffee blend is less effective at stimulating gastric acid secretion in healthy volunteers
compared to a medium roast market blend. Mol Nutr Food Res., 58(6), 1370–3.
Rufián-Henares, J.A. and Morales, F., 2007. Functional Properties of melanoidins: In vitro antioxidant,
antimicrobial and antihypertensive activities. Food Research International, 40(8), 995–1002.
Ryan, L., Hatfield, C. and Hofstetter, M., 2002. Caffeine reduces time-of-day effects on memory
performance in older adults. Psychological Science, 13(1), 68–71.
Saab, S., Mallam, D., Cox, G.A. and Tong, M.J., 2014. Impact of coffee on liver diseases: A systematic
review. Liver International, 34(4), 495–504.
Sales, A., Miguel, M. A. and Farah, A., 2017. Potential prebiotic effect of coffee. In Coffee: Chemistry
Quality and Health Implications (Ed.: Farah, A.). Royal Society of Chemistry, London, UK. In press.
Santos, M. D., Almeida, M. C., Lopes, N. P. and Souza, G. E. P. 2006, Evaluation of the anti-
inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid.
Biological and Pharmaceutical Bulletin 29, 2236–40.
Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A. and Lunet, N., 2010. Caffeine intake and dementia:
Systematic review and meta-analysis. Journal of Alzheimer’s Disease 20(S1), 187–204.
Santos, I. S., Matijasevich, A. and Domingues, M.R., 2012. Maternal caffeine consumption and infant
nighttime waking: Prospective cohort study. Pediatrics 129, 860–8.
Satel, S., 2006. Is caffeine addictive? – a review of the literature. American Journal of Drug and
Alcohol Abuse 32 (4), 493–502.
Sengpiel. V., Elind, E., Bacelis, J., Nilsson, S., Grove, J., Myhre, R., Haugen, M., Meltzer, H. M.,
Alexander, T., Jacobsson, B. and Brantsaeter, A. L., 2013. Maternal caffeine intake during
pregnancy is associated with birth weight but not with gestational length: results from a large
prospective observational cohort study. BioMed Central Medicine 11, 42–60.
Smith, A., Sutherland, D. and Christopher, G., 2005. Effects of repeated doses of caffeïne and mood
and performance of alert and fatigued volunteers. Journal of Psychopharmacology 19(6), 620–6.
Smith, R. F., 1987. A History of coffee. In:Coffee: Botany, Biochemistry and Production of Beans and
Beverage (Clifford, M. N.and Wilson, K. C. (Eds)). 1st edition, Croom Helm, Ney York, pp. 1–12.
Somoza V., Lindenmeier M., Wenzel E., Frank O., Erbersdobler H. F., and Hofmann T. (2003). Activity-
guided identification of a chemopreventive compound in coffee beverage using in vitro and in
vivo techniques. J. Agric. Food Chem., 51 (23), 6861–9.
© Burleigh Dodds Science Publishing Limited, 2018. All rights reserved.
Nutritional and health effects of coffee 31
Speer, K. and Kölling-Speer, I.2017. Lipids. In: Coffee: Chemistry, Quality, and Health Implications
(Ed.: Farah, A.).Royal Society of Chemistry, London, UK. In press.
Spriet, L. L. and Gibala, M. J., 2004. Nutritional strategies to influence adaptations to training.Journal
of Sports Sciences 22, 127–41.
Stavchansky, S., Combs, A., Sagraves, R., Delgado, M. and Joshi, A., 1988. Pharmacokinetics
of caffeine in breast milk and plasma after single oral administration of caffeine to lactating
mothers. Biopharmaceutics and Drug Disposition 9, 285–99.
Terry, P., Lagergren, J., Wolk, A. and Nyren, O., 2000. Reflux-inducing dietary factors and risk of
adenocarcinoma of the esophagus and gastric cardia. Nutrition and Cancer 38(2), 186–91.
Tohda, C., Kuboyama, T. and Komatsu, K., 2005. Search for natural products related to regeneration
of the neuronal network. Neurosignals 14(1–2), 34–45.
Torres, T. and Farah, A., 2016. Coffee, maté, açaí and beans are the main contributors to the
antioxidant capacity of Brazilian’s diet. European Journal of Nutrition March 14. 56(4):1523–33.
doi:10.1007/s00394-016-1198-9.
Trugo, L. C., 1985. Carbohydrates. In: Coffee. Volume 1 Chemistry, 1st Ed. (Ed.: Clarke, R. J.and
Macare, R.).Elsevier, London and New York, p.83.
Ukers, W. H., 1935. All About Coffee, 2nd Ed. Tea and Coffee Trade Journal Co., New York.
United States Department of Agriculture (USDA), 2015. USDA Scientific Report of the Dietary
Guidelines Advisory Committee.
Urgert, R., van der Weg, G., Kosmeijer-Schuil, T. G., van de Bovenkamp, P., Hovenier, R. and Katan, M.
B., 1995. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee
brews.Journal of Agricultural and Food Chemistry 43(8), 2167–72.
Urgert, R. and Katan, M. B., 1997. The cholesterol-raising factor from coffee beans. Annual Review of
Nutrition 17, 305–24.
USDA National Nutrient Database for Standard Reference (Release 28, released September 2015, slightly
revised May 2016) United States Department of Agriculture, https://ndb.nal.usda.gov/ndb/.
USDA National Nutrient Database, 2017. United States Department of Agriculture, Agricultural Research
Service, USDA Food Composition Databases, https://ndb.nal.usda.gov/ndb/, Accessed in
February 13 2017.
van Boxtel, M. P. J. and Schmitt, J. A. J., 2004. Age related changes in the effects of caffeine on
memory and cognitive performance. In: Coffee, Tea, Chocolate and the Brain (Ed.: Nehlig,
A.).CRC Press, Boca Raton, Florida, pp. 85–97.
van Dijk A.E., Olthof, M. R., Meeuse, J. C., Seebus, E., Heine, R. J. and van Dam, R. M., 2009.
Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and
trigonelline on glucose tolerance.Diabetes Care 32, 1023–5.
Vitaglione, P., Fogliano, V. and Pellegrini, N., 2012. Coffee, colon function and colorectal cancer. Food
and Function 3, 916–22.
Waite, M., 2015. Treatment for Alzheimer’s disease: Has anything changed? Australian Prescriber 38, 60–3.
Wang W., Basinger A., Neese R. A., Shane B., Myong S. A., Christiansen M. and Hellerstein M. K.
2001. Am J Effect of nicotinic acid administration on hepatic very low density lipoprotein-
triglyceride production. Physiol Endocrinol Metab. 280, 3, E540–7.
WHO/FAO (World Health Organization and Food and Agriculture Organization of the United Nations),
2002. Human vitamin and mineral requirements. Report of a Joint FAO/WHO Expert Consultation,
Bangkok, Thailand.FAO, Rome. http://www.fao.org/docrep/004/y2809e/y2809e00.htm
WHO 2017, http://www.who.int/mediacentre/factsheets/fs310/en/accessed in January 2017.
Yamamoto, T., Yoshizawa, K., Kubo, S., Emoto, Y., Hara, K., Waters, B., Umehara, T., Murase, T. and
Ikematsu, K., 2015. Autopsy report for a caffeine intoxication case and review of the current
literature. Journal of Toxicologic Pathology 1, 33–6.
Yoshinari, O. and Igarashi, K., 2010. Anti-diabetic effect of trigonelline and nicotinic acid, on KK-Ay
mice. Current Medicinal Chemistry 17(20), 2196–202.
Youngberg, M. R., Karpov, I. O., Begley, A., Pollock, B. G. and Buysse, D. J., 2011. Clinical and
physiological correlates of caffeine and caffeine metabolites in primary insomnia. Journal of
Clinical Sleep Medicine 7, 196–203.